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Abstract
Introduction: It is well documented that insulin offers cardioprotection under
ischaemic stress. In the past it was believed that the protective effects of insulin, such
as the (a) recruitment of glucose transporters to enhance glucose entry into the cell, (b)
stimulation of glycolysis, (c) enhancement of glycogen synthesis, (d) improved protein
synthesis, and (e) positive inotropic and chronotropic properties, were metabolic of
origin, but lately the emphasis has shifted towards the diverse signal transduction
pathways elicited by insulin. Although these beneficial effects of insulin on
ischaemia/reperfusion induced injury have been studied for many years, the exact
protective mechanism is still not resolved. Aim: To investigate the influence of insulin
on the signaling pathways as a possible protective mechanism against
ischaemia/reperfusion and therefore to investigate the possible roles and cross
signaling of cyclic adenosine monophosphate (cAMP), protein kinase B (PKB) and p38
mitogen activated protein kinase (p38 MAPK) in the cardioprotection offered by insulin
to the reperfused, ischaemic myocardium. Materials and methods: Isolated rat hearts
were perfused retrogradely in accordance with the Langendorff technique (95%02, 5%
C02). After 30 min of stabilization, hearts were subjected to 30 min global low flow
ischaemia (0,2 ml/min), followed by 30 min of reperfusion. Hearts perfused with
standard Krebs Henseleit solution containing 5 mM glucose were compared to hearts
perfused with a perfusion solution containing 5 mM glucose and 0,3 IlIU/ml insulin.
Wortmannin was added during either ischaemia or reperfusion. Left ventricular
developed pressure (LVDP), rate pressure product (RPP), tissue cAMP and PKB and
p38 MAPK activation were measured. Results: Insulin treated hearts showed
improved functional recovery (P<0.05) during reperfusion after ischaemia vs. non-
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insulin treated hearts (85.5±4.6% vs. 44.8±4.9%). However, the addition of
wortmannin (a Pl3-kinase inhibitor) to the perfusion solution during either ischaemia or
reperfusion abolished the improved recovery. At the end of ischaemia, cAMP levels of
the insulin treated hearts were elevated significantly, while the cAMP content in the
non-insulin treated hearts returned to control levels. Addition of wortmannin during
ischaemia abolished this rise in cAMP. Wortmannin added during reperfusion only did
not alter the levels of cAMP at the end of reperfusion. Activation of p38 MAPK was
transient during ischaemia for both insulin and non-insulin treated hearts. Addition of
wortmannin during ischaemia did not alter p38 MAPK levels at the end of ischaemia.
P38 MAPK was activated significantly (P<0.001) in the non-insulin treated hearts vs.
insulin treated hearts during reperfusion. Wortmannin, added at the onset of
reperfusion, could partially abolish the effects of insulin to suppress p38 MAPK
activation after 30 min of reperfusion. Activation of PKB in insulin treated hearts was
significantly higher than non-insulin treated hearts during stabilization and early
ischaemia. This activity was depressed by 30 min of ischaemia in both presence and
absence of insulin. Wortmannin, when added before induction of ischaemia did not
further lower this. The presence of insulin resulted in occurrence of strong PKB
activation during reperfusion, peaking at 15 minutes and diminishing at 30 minutes.
Wortmannin, added at the onset of reperfusion, abolished PKB activity measured at the
end of reperfusion. Conclusion: Insulin exerted a positive inotropic effect and delayed
the onset to ischaemic contracture. Inhibition of Pl3-kinase by wortmannin abolished
the protective effects of insulin, arguing for an insulin stimulated PKB involvement in
cardiac protection. Insulin also increased cAMP production and attenuated activation
of p38 MAPK, both associated with improved recovery. This evidence suggested
possible cross signaling between different signaling pathways.
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Uittreksel
Agtergrond: Insulin beskerm harte wat aan isgemiese stres blootgestel word.
Alhoewel hierdie voordelige effekte van insulien reeds vir verskeie jare bestudeer is, is
die presiese meganisme waarmee insulien die hart beskerm steeds nie duidelik nie.
Navorsers het die beskermende effekte van insulien aan metaboliese gevolge soos: (a)
verhoogde glukose transport d.m.v. inspanning van meer glukose transporters (b),
stimulering van glikolise, (c) vebeterde glikogeensintese, (d) verhoogde
proteiensintese, en (e) die positiewe inotropiese en chronotropiese eienskappe van
insulien toegeskryf. Onlangs het die fokus verskuif na ander diverse
seintransduksiepaaie. Doel: Die doel van hierdie studie was dus om die moontlike
betrokkenheid van hierdie sientransduksiepaaie asook die interaksie tussen sikliese
adenomonofosfaat (cAMP), proteïn kinase B (PKB) en p38 MAPK in die beskerming
wat insulien aan die isgemiese, gereperfuseerde miokardium bied, te bestudeer.
Materiale en Metodes: Geïsoleerde rotharte is geperfuseer in ooreenstemming met
die Langendorff metode. Na 30 min van stabilisasie is harte blootgestel aan 30 min.
globale lae vloei isgemie (0,2 ml/min), en daarna is harte vir 30 min. geherperfuseer.
Harte wat geperfuseer is met 'n perfusaat wat 5mM glukose bevat is vergelyk met
harte wat geperfuseer is met 'n perfusaat wat 5mM glukose en 0,3 ~IU/ml insulien
bevat. Sommige harte is geperfuseer met 'n perfusie oplossing waar wortmannin
bygevoeg is tydens óf isgemie óf tydens herperfusie. Linker ventrikulêre ontwikkelde
druk (LVDP), tempo-druk produk (RPP), weefsel cAMP-vlakke asook PKB en p38
MAPK aktiwiteit is gemeet. Resultate: Insulien-behandelde harte het funksioneel
beduidend beter herstel tydens herperfusie na isgemie as harte wat nie met insulien
behandel is nie (85.5±4.6% vs. 44.8±4.9%). Byvoeging van wortmannin by die
v
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perfusie oplossing tydens óf isgemie óf reperfusie, het die toename in herstel wat
gesien is in die insulien-behandelde harte, opgehef. Die cAMP vlakke in die insulien-
behandelde harte het aan die einde van isgemie beduidend gestyg (P<0.001), terwyl
vlakke in harte wat nie met insulien behandel is nie, na kontrole vlakke teruggekeer
het. Die teenwoordigheid van wortmannin in die perfusie oplossing tydens isgemie, het
die styging in cAMP voorkom , terwyl die byvoeging van wortmannin tydens
herperfusie. nie die cAMP vlakke beïnvloed het nie. Die aktivering van p38 MAPK
tydens isgemie was van verbygaande aard in beide die insulien-behandelde harte en
harte wat nie met insulien behandel is nie. Die byvoeging van wortmannin tydens
isgemie het nie die p38 MAPK aktivering beïnvloed nie. P38 MAPK is beduidend
geaktiveer tydens herperfusie in harte wat nie met insulien behandel is nie vergeleke
met die insulien-behandelde harte. Die byvoeging van wortmannin tydens reperfusie
kon die effek van insulien om p38 MAPK aktivering te onderdruk, gedeeltelik ophef.
PKB aktivering tydens die stabilisasie fase en vroeë isgemie was beduidend hoër in die
insulien-behandelde harte vs. die harte wat nie met isulien behandel is nie. Die
aktiwiteit is onderdruk deur 30 min isgemie ongeag die teenwoordigheid van insulien.
Die byvoeging van wortmannin tydens isgemie het PKB aktivering nie verder verlaag
nie. Die teenwoordigheid van insulien het 'n sterk aktivering van PKB tydens
herperfusie veroorsaak met 'n piek na 15 min en 'n verlaging na 30 min. Wortmannin
bygevoeg aan die begin van herperfusie, het PKB aktiwiteit opgehef aan die einde van
reperfusie. Opsomming: Insulien het 'n positiewe inotropiese invloed gehad, en het
die begin van isgemiese kontraksie vertraag. Die inhibisie van Pl3-kinase deur
wortmannin het die beskermende effekte van insulin opgehef, wat 'n insulin
gestimuleerde PKB betrokkenheid aandui. Insulien het ook verhoogte cAMP produksie
en verlaagde p38 MAPK aktivering tot gevolg gehad, en beide is geassosieer met
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verbeterde herstel. Hierdie resultate dui dus op moontlike interaksie tussen die
verskillende seintransduksiepaaie.
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Chapter 1
INTRODUCTION
Insulin influences and improves all the aspects of metabolism of the heart, but the
precise mechanism and signaling pathways by which it operates, is still not clear.
Insulin is a major regulatory hormone of carbohydrate metabolism in the heart
(Taegtmeyer, 1994). Insulin promotes glucose entry into the cell and stimulates
glycolysis, it enhances synthesis of glycogen, fatty acids and proteins, and inhibits
glycogen and fat utilization (King & Opie, 1995). Insulin per se was shown to have
cardioprotective properties. Van Rooyen et al. (1998) found that the administration of
insulin improved the recovery of cardiac output during reperfusion through an increase
in glucose uptake and stimulation of glycolysis during low flow ischaemia. The
cardioprotective effect of insulin was also investigated by Jonassen et al. (1996) as
part of the effect of a Glucose-Insulin-Potassium (Sodi-Pallares) cocktail. They found a
reduction in infarct size when insulin was administered at the onset of reperfusion in
both in vivo and isolated rat heart preparations. They subsequently focused their
attention on insulin activated signal transduction pathways and the putative role of
apoptosis in this cardioprotection exerted by insulin (Jonassen et al. 2000). In view of
these interesting results, the aim of the present study was to further investigate the
signal transduction pathways of insulin in the myocardium. However, our study differed
from that of Jonassen and co-workers in that insulin was administered throughout the
entire perfusion period, whereas they added insulin only during reperfusion. In
addition, they used total global ischaemia compared to global low flow ischaemia in our
study. We used recovery of mechanical function as endpoint compared to apoptosis
and infarct size of the myocardium in their study.
1
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2It is known that insulin exerts some of its effects through the activation of the protein
kinase B (PKB) signaling pathway, which in tum, mediates its metabolic effects. As
this is a well-recognized survival mechanism (Downward, 1998) we investigated the
involvement of insulin stimulated signaling pathways in cardioprotection of the rat heart
during ischaemic stress.
During ischaemia and reperfusion, the metabolism of the myocardium changes, and it
is characterized by an ATP shortage, the inhibition of glycolytic enzymes, altered
membrane pump functioning, acidosis, and the accumulation of cyclic adenosine
monophosphate (cAMP) (Opie, 1975; Wollenberger, 1969). However, the precise role
of cAMP in the isolated perfused rat heart subjected to low-flow ischaemia, is not well
documented. It is well established that cAMP production is directly related to
myocardial contractility and accumulation thereof may even be harmful to the
ischaemic heart. Furthermore, cAMP may lead to both PKB and p38 mitogen activated
protein kinase (MAPK) activation. We therefore studied cAMP levels and possible links
with other parameters and functional recovery in a model of low-flow ischaemia.
Several stress signal transduction pathways are activated by ischaemia and
reperfusion. These pathways include the c-Jun NH2-terminal kinase (JNKs), p38
MAPK and the extracellular signal-regulated kinases (ERKs) (Sudgen & Clerk, 1998).
Whether these signaling pathways may play a protective or deleterious role during
ischaemia and reperfusion is not well understood. We therefore investigated this
controversial aspect of the stress signal transduction pathways, and a possible link with
other cellular mechanisms and functional recovery of the hearts after low flow
ischaemia.
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3The aim of this study was thus to investigate the possible roles for cAMP, PKB and p38
MAPK in the cardioprotection offered by insulin in the low flow ischaemic/reperfused
myocardium.
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Chapter 2
LITERATURE REVIEW
2.1 Ischaemia and reperfusion damage
Myocardial ischaemia occurs when the reduction of coronary flow is so severe that the
supply of oxygen to the myocardium is inadequate for the demands of the tissue (Opie,
1998).
Myocardial ischaemia is a multifactoral process and is characterized by numerous
changes in the tissue for example, loss of high energy phosphates (ATP + CP),
accumulation of metabolites (eg. lactate), and acidosis (Opie, 1998). These changes
are initially reversible but become irreversible when the period of ischaemia exceeds a
certain limit. Should coronary flow be restored before the onset of irreversible injury,
these ischaemic-induced changes can largely be reversed. Four main factors indicate
irreversible ischaemie damage:
1) Critical ATP loss, 2) membrane damage, 3) mechanical effects such as cell swelling
and membrane rupture as a result of elevated osmotic pressure, and finally 4) calcium
overload (Opie, 1984; Opie, 1998).
Reperfusion improves the myocardial metabolism via increased washout of harmful
metabolic products (Neely & Grotyohann, 1984), resumption of contractile activity, and
by providing oxygen and nutrients to the ischaemie myocardium. While early
reperfusion of the heart is essential in preventing further tissue damage due to
ischaemia, reintroduction of blood flow can expedite the death of vulnerable, but still
viable myocardial tissue, by initiating a series of events involving both intracellular and
extracellular mechanisms, the so-canecrepertusion injury (Park et al., 1999).
4
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5Reperfusion injury includes conditions such as postischaemic contractile dysfunction
("myocardial stunning"), reperfusion arrhythmias and lethal reperfusion injury (Piper et
al., 1998).
It is suggested that reperfusion mediated injury is largely a consequence of injury
during ischaemia, and can thus be effectively inhibited by the prevention of these
ischaemic-specific events (Vanoverschelde et al., 1994).
The mechanism of reperfusion injury appears to be metabolic of origin, related to either
free radical formation or excess accumulation of cytosolic Ca2+ (Opie, 1987), or a
combination of these factors (Bolli, 1992). Reperfusion of postischaemic tissues is
accompanied by generation of large amounts of oxygen radicals, formed by various
mechanisms, which can overwhelm cellular defenses and induce cellular damage
(Ambrosia et al., 1991; Zweier et al., 1987). According to Bolli (1990), compelling
evidence indicates that the free radical damage occurs in the initial moments of reflow,
so that myocardial stunning can be viewed as a sub-lethal form of oxyradical-mediated
reperfusion injury.
The other crucial factor influencing reperfusion injury is the transient calcium overload
during early reperfusion that contributes to postischaemic dysfunction ("stunning")
(Tani & Neely, 1989; Bolli, 1990). Opie (1998) suggested that the intemal calcium
overload could damage the contractile apparatus to impair the normal physiological
response to calcium, resulting in myocardial stunning. Application of calcium channel
blockers or modulation of calcium flux via the sarcoplasmic reticulum during early
reperfusion resulted in a decrease in the severity of stunning, and thus protection (Du
Toit & Opie, 1992).
The calcium- and free radical-mediated components of the damage may be interactive.
Free radicals may also inhibit the uptake of calcium by the sarcoplasmic reticulum,
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6inhibit the sodium pump, stimulate Na+/Ca+ exchange, and decrease the rate of
inactivation of the calcium current (Opie, 1991).
The composition of the reperfusion solution may affect the incidence of reperfusion
arrhythmias. During reperfusion, fatty acid oxidation quickly recovers and dominates
as the source of energy. The main consequence of this is that glucose oxidation rates
are markedly inhibited. As a result, high glycolytic rates, possibly due to increased
glucose transport, and low glucose oxidation rates can result in a substantial
uncoupling of glycolysis from glucose oxidation (Lopaschuk, 1997). This uncoupling of
glycolysis from glucose oxidation contributes to the production of protons from glucose
metabolism during reperfusion, which can contribute to reperfusion injury (Lopaschuk,
1994; Liu et al., 1996). Therefore it appears that the stimulation of glucose oxidation,
either directly or by inhibiting fatty acid oxidation, results in a significant increase in
cardiac function and efficiency (Lopaschuck, 1994). In this regard, the inhibitory effect
on reperfusion ventricular arrhythmias of glucose oxidation versus fatty acid oxidation
is well established (Manning & Hearse, 1984: Bemier & Hearse, 1988; Coleman et al.,
1989).
2.2 Manipulation of the outcome of ischaemia-reperfusion
2.2.1 Glucose-Insulin-Potassium
2.2.1.1 Theory
Glucose-Insulin-Potassium (GIK) therapy was advocated for the treatment of acute
myocardial infarction, initially as a polarizing agent to provide electrical stability and
later as a metabolic support (Fath-Ordoubadi & Beatt, 1997).
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72.2.1.2 The old rationale for GIK
In the early 1960's, Sodi-Pallares and his co-workers (1962) performed pioneering
work on the effects of the administration of a GIK solution to the heart after infarction.
They suspected that the cause of damage after myocardial infarction was a possible
ionic disturbance, and thoroughly studied the effect of GIK on the electrocardiographic
signs of myocardial insults.
They considered that the resting or diastolic polarization of the cardiac fibers was due
to the ratio of the potassium inside the cell (Kj+),to that on the outside (Ko+)of the cell.
Consequently, any disturbance of either the diastolic polarization or the Kj+/Ko+ratio
would influence one another. Since potassium influences the excitability and
contractility of cardiac muscle by means of the ionic interrelationship at the cellular
level, it plays a major role in determining the state of polarization of the cell (Gautam,
1969), and any disturbance of the Kj+IKo+ ratio would therefore result in disturbance of
the resting membrane potential and generation of ventricular arrhythmias that could be
fatal.
Sodi-Pallares and his co-workers thus hypothesized that forcing K+ into the fibers
should modify the trans-membrane potassium ratio, and normalize the ionic exchange.
Addition of glucose and insulin to the so-called Sodi-Pallares solution was based on
their known beneficial actions on K+ movements and glucose uptake. At that time
Muntz (1959) concluded that insulin increased the intracellular accumulation of glucose
and potassium, thereby enhancing the process of oxidative phosphorylation and the
transfer of high-energy phosphate from phosphopyruvate to ADP and ATP. During the
sixties, the administration of this polarizing treatment was used successfully in at least
two independent trials, showing its cardioprotective effect after a myocardial infarction
(Mittra, 1965; Sodi-Pallares, 1962).
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8Subsequently, GIK was proven to be a safe and effective intervention, also for the
treatment of patients in cardiogenic shock after hypothermic ischaemic arrest for
coronary bypass surgery (Gradinak et al., 1989; Taegtmeyer & Villalobos, 1995).
Clinical studies conducted by Diaz et al. (1998) furthermore showed a reduced
mortality in patients with acute myocardial infarction (AMI) undergoing GIK reperfusion
therapy.
Unfortunately, the notion of GIK treatment in acute myocardial infarction was received
negatively by many scientists and clinicians because of subsequent studies that
questioned the efficacy of this treatment. For example, a study by the Medical
Research Council Working Party, found no significant difference in mortality between
the GIK-treated and the untreated control groups (23,9% vs. 23,3%). This report
played a significant role in discrediting GIK therapy (British Medical Research Council,
1968).
Fath-Ordoubadi and Beatt (1997) overviewed the randomized placebo-controlled GIK
trials, and concluded that the results were inconclusive because of several factors,
including a low number of recruits, poor design and methodological discrepancies
between different clinical trials.
2.2.1.3 The new rationale for GIK
Despite the inconclusive and negative results described above, the interest in the
concept of myocardial GIK-induced salvage in acute myocardial infarction did not
disappear. The "old" and "new" rationales for the metabolic support of the ischaemic
and postischaemic myocardium with GIK complement each other. Whereas earlier
researchers focused more on the recovery of the disturbance of polarization of the
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9cells, later studies shifted their focus to prevent further tissue damage by improving the
metabolic milieu of the heart by restoring energy flux (Taegtmeyer, 1995).
2.2.1.4 Mechanism of Action
During ischaemia, exogenous glucose has been shown to be a more efficient fuel than
free fatty acids (FFA) or glycogen and is more likely to prevent ischaemie myocardial
injury (Runnman & Weiss, 1988). In particular, glycolytic-derived ATP preferentially
supports cell membrane function by protecting membrane ion transport and hence
helps to preserve cell integrity (Lochner et al., 1996; Weiss & Lamp, 1987).
During myocardial ischaemia, high concentrations of FFA, provoked by high
sympathetic activity (Gupta et al., 1969; Opie et al., 1977) have been shown to lead to
increased myocardial oxygen requirements and depression of myocardial activity and
contraction (Oliver & Opie, 1994; Mj0s, 1971). During ischaemia, B-oxidation of FFA is
reduced, which in turn, results in intracellular accumulation of acylcamitine and acyl
coenzyme A. Acylcamitine inhibits the sarcoplasmic reticulum Ca2+ pump, the
sarcolemmal Na+/Ca2+ exchanger, and the Na+ pump. It can also activate Ca2+
channels and increase cyclic AMP levels (Apstein, 2000). Acyl coenzyme A might be
involved in many of the deleterious effects of ischaemia, particularly arrhythmogenesis
(Opie, 1975). Soboll et al. (1984) also found that long-chain acyl coenzyme A exerts
an inhibitory effect on mitochondrial adenine nucleotide translocation (ATP-ADP
translocase) in the cell.
These actions may cause the impairment of calcium homeostasis (Saman et al., 1988),
and the production of free radicals, leading to instability and ventricular arrhythmias,
and ultimately to cell membrane damage (Kurien & Oliver, 1970).
NlVERSITEIT STEli.E!':SOSCH
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However, in the presence of a high glucose and insulin concentrations, the inhibition of
glycolysis by FFA is minimal, while high circulating levels of glucose and insulin both
depress plasma levels of FFA and decrease myocardial FFA uptake at any given
plasma FFA level (Oliver& Opie, 1994; Opie, 1975).
GIK may therefore act beneficially via an anti lipolytic mechanism, and by supporting
membrane stability.
2.2.1.5 Reperfusion strategies
Studies conducted by Vanoverschelde and co-workers (1994) support the
complementary roles of GIK and reperfusion therapy. They observed that through the
reduction in the extent of myocardial ischaemie damage and suppression of FFA
levels, GIK therapy helped to prevent reperfusion injury that may occur after successful
revascularization.
GIK protects the cell membrane of ischaemie myocytes, as well as endothelial and
vascular smooth muscle cells, and that may improve reflow after reperfusion and
protect against no-reflow phenomenon by reducing cell swelling and microvascular
compression (Eberli et al., 1991).
The sound theoretical rationale for the beneficial effect of GIK, its complementary role
with reperfusion strategies, and very low incidence of serious side effects with proper
monitoring provides a definite reason for further investigation and clinical application.
The mechanisms underlying GIK mediated cardioprotection are, however, still unclear.
Recent data implicates insulin "alone" as the major protagonist of cardioprotection
when administered at the time of reperfusion (Jonassen, 2000).
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2.2.2 Glucose
2.2.2.1 Myocardial metabolism
During normoxia, the circulating free fatty acids (FFA) are the major fuel source for
normal functioning of the heart (Bing, 1954; Brachfeld & Scheuer, 1967). During
ischaemia, a shift occurs from aerobic to anaerobic metabolism (Oliver & Opie, 1994),
since oxygen deficiency prevents the oxidation of non-glucose substrates such as fatty
acids. The heart becomes totally reliant on anaerobic glycolysis during ischaemia.
The rate of utilization of glucose or glycogen may determine the degree of survival of
the ischaemic heart (apie, 1998, Cascarano et al., 1968; Scheuer & Stezoski, 1969;
Weissler et al., 1968). Therefore the provision of appropriate energy-giving substrates,
such as glucose, may protect against ischaemie injury (Olivier & Opie, 1994).
The metabolism of the ischaemie myocardium is characterized by an ATP shortage, as
well as inhibition of glycolytic enzymes by the accumulation of lactate and concomitant
intracellular acidosis. Other detrimental changes include inadequate functioning of
membrane pumps (apie, 1990), potassium (K+) loss in the ischaemic zone (Opie,
1970; Weiss and Lamp, 1987), sarcolemmal damage (Williamson et al., 1976),
accumulation of cAMP (Wollenberger et al., 1969), and deficient Ca2+ homeostasis
(Henry et al., 1977).
2.2.2.2 Glucose as energy bearing substrate
It is well established that increased provision of glucose is beneficial to the ischaemic
myocardium (apie, 1998). Indices of protection include a reduction of reperfusion-
induced arrthythmias (Bernier & Hearse, 1988), the attenuation of stunning (Ferrari et
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al., 1985), and a decrease in the occurrence of ischaemie contracture (Owen et al.,
1990).
The mechanism underlying the protection conferred may be attributed to the increased
production of glycolytic ATP (Owen et al., 1990), and the resultant improvement in
cytosolic Ca2+ homeostasis (Opie, 1989). De Leiris et al. (1975) reported lower
enzyme release in glucose perfused, ischaemie hearts, indicating a beneficial effect of
glucose on sarcolemmal permeability. This was later confirmed by Lochner and co-
workers (1996) who demonstrated the beneficial effects of glucose, using lanthanum to
quantify sarcolemmal permeability.
To maximize glucose uptake into the myocytes, there must be adequate glucose
delivery by the coronary blood flow and efficient transport of glucose from the blood to
the interstitial space and finally the cytosol (King et al., 1995).
Anoxia, where the oxygen tension is reduced, promotes glucose transport into the cell
(Morgan et al., 1961). Similarly, moderate ischaemia, during which oxygen deprivation
is due to limited coronary flow, also enhances glucose uptake (Rovetto et al., 1973).
However, during severe ischaemia, when the coronary flow is drastically reduced,
glucose uptake is reduced since delivery to the myocardium is restricted (Achs &
Garfinkel, 1977; Rovetto et al., 1973).
While anoxia accelerates glucose transport, the rate of anaerobic glycolysis is
enhanced by reduced inhibition of glycolytic enzymes. Accumulation of free fatty acids
and loss of high-energy phosphate compounds within the cell are responsible for this
enzymatic inhibition during normoxia (Opie, 1975). In moderate ischaemia, the major
portion of the glucose taken up enters the Krebs Cycle to produce energy via oxidative
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metabolism. Severe ischaemia limits flux through the Krebs Cycle and lactic acid
accumulates within the myocardium (Rovetto et al., 1973). Together with protons
(generated by the breakdown of ATP), lactate inhibits glycolytic enzymes such as
phosphofructokinase (PFK), hexokinase (HK), phosphorylase kinase C, and
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) (Neely et al., 1975).
Thus during ischaemia, glycolytic flux is regulated by both the rate of glucose delivery
and the severity of enzymatic inhibition. As coronary flow is reduced, metabolic
accumulation and the influence of thus metabolic inhibition become increasingly
important, limiting glycolytic flux (King et al., 1995). This may explain why glycolytic
flux is enhanced during mild ischaemia, and inhibited during severe ischaemia (Opie,
1990).
2.2.3 Insulin
Insulin is a major regulatory hormone of carbohydrate metabolism in the heart
(Taegtmeyer, 1994). Insulin promotes glucose entry into the cell (see 1.2.3.2.2) and
stimulates glycolysis (see 1.2.3.2.2.4), enhances synthesis of glycogen (see
1.2.3.2.2.3), fatty acids and proteins (see 1.2.3.2.2.5), and inhibits glycogen and fat
utilization (King & Opie, 1995). Insulin was shown to have cardioprotective properties.
Van Rooyen et al. (1998) found that the administration of insulin improved cardiac
output recovery during reperfusion through an increase in glucose uptake and
stimulation of glycolysis during low flow ischaemia. The cardioprotective effect of
insulin as part of the effects of GIK (Sodi-Pallares) cocktail was further investigated by
Jonassen et al. (1996). They found a reduction in infarct size when insulin was given
at the onset of reperfusion in both the in vivo and the isolated rat heart preparation.
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2.2.3.1 Insulin receptor, IRS-1, and Phosphatidylinositol 3-kinase (PI3-K)
Insulin receptor activation promotes an intrinsic tyrosine kinase activity, which leads to
insulin receptor substrate 1 (IRS-1) phosphorylation. IRS-1 binds with Src homology 2
containing proteins (SH2-phosphotyrosine binding sites), including Pl3-Kinase, Ras
GTPase-activating protein, phospholipase C and others (Myers, 1994). Pl3-kinase
may eventually activate protein kinase B (PKB) and mediate translocation of the insulin
sensitive glucose transporter, GLUT 4, to the sarcolemmal membrane (Myers, 1994;
Sun et al., 1994), which in tum, leads to increased glucose uptake and glycogen
synthesis.
2.2.3.2 Protein kinase B (PKB)
Protein kinase B/Akt was cloned by virtue of its homology to the A and C protein
kinases, and is the cellular homologue of the product of the v-akt oncogene (Bellacosa
et al., 1991; Coffer & Woodgett, 1991; Jones et al., 1991).
Protein kinase B is a member of the second messenger-dependent family of
serine/threonine kinases that have been implicated in signaling pathways downstream
of growth factor receptor tyrosine kinases (Meier et al., 1997).
2.2.3.2.1 Activation of PKB (Fig. 2.1)
PKB is activated in response to treatment of cells with a wide variety of growth stimuli,
including platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin,
thrombin and nerve growth factor (NGF) (Downward, 1998). Several findings indicate
that PI3-K is involved in the regulation of PKB, for example, growth factor as well as
insulin-induced activation of PKB is inhibited by the PI3-K inhibitor wortmannin (Franke
et al., 1995; Burgering & Coffer, 1995; Kohn et al., 1995). PKB is also inhibited by the
14
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expression of a dominant negative form of PI3-K (Burgering & Coffer, 1995), and in the
case of PDGF, it is inhibited by mutation of PDGF receptor tyrosines 740 and 751,
which bind to the PI3-K regulatory subunit (Franke et al., 1995; Burgering and Coffer,
1995). PI3-K activity is thus required for the regulation of PKB by growth factors
(Klippel et at., 1996; Marte et aL, 1997; Franke et al., 1997; Didichenko et al., 1996).
As PI3-K is stimulated by direct interaction with the p110 catalytic subunit (Rodrigues-
Viciana et al., 1994; Rodrigues-Viciana, 1996) of the small GTP binding protein, Ras,
PKB is also controlled by Ras (Klippel et al., 1996; Marte et al., 1997; Datta et al.,
1996).
In addition to PI3-K-mediated regulation of PKB, another pathway for the regulation of
PKB exists that is not sensitive to PI3-K inhibitors such as wortmannin (Downward,
1998). Cellular stresses such as heat shock and hyperosmolarity, or
ischaemia/reperfusion, which also activate the p38 MAPK cascade, are able to
stimulate the activity of PKB in a wortmannin insensitive manner (Konishi et al., 1997).
Heat shock induces association of PKC8 with the pleckstrin homology (PH) domain of
PKB (Konishi et al., 1994).
In addition, PKB can also be activated by increases in intracellular cAMP
concentrations in a manner that is independent of PI3-Kinase. This activation does not
appear to be due to a direct phosphorylation of PKB by PKA, but is ultimately related to
the same mechanism as the one used by PI3-Kinase, that is phosphorylation of Thr308
and Ser473 of PKB (Sable et al., 1997).
PI3-K activation results in the production of PI(3,4)P2 and PI(3,4,5)P3. The binding of
the pleckstrin homology (PH) domain of PKB to these phosphoinositides recruits PKB
to the plasma membrane (Downward, 1998) where it undergoes a conformational
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change (Hemmings, 1997) allowing the enzyme to become phosphorylated (activated)
on Thr308 by PDK1 (Phosphoinositide dependent kinase)-1 and on Ser473 by PDK2.
The activity, or possibly location, of PDK1, and perhaps PDK2, may also be regulated
by Pl3-Kinase products (Downward, 1998). Subsequently, PKB is released from the
membrane to phosphorylate specific targets (Hemmings, 1997).
2.2.3.2.2 Downstream effects of PKB activation
2.2.3.2.2.1 Insulin and the metabolic effects of PKB
Activated PKB mediates a number of metabolic effects of insulin by phosphorylating its
cellular substrates (Downward, 1998).
2.2.3.2.2.2 Glucose transport (GLUT 4 + GLUT 1)
One of the major metabolic responses invoked by insulin challenge is the stimulation of
glucose transport in muscle and adipose tissue by recruiting glucose transporters
(GLUT 1 and GLUT 4) to the cell surface from intracellular pools (Coffer et al., 1998).
The insulin-sensitive glucose transporter, GLUT 4, is distributed between vesicles in
the cytosolic pool and the plasma membrane (James et al., 1989).
Insulin acutely stimulates glucose transport in muscle and fat by recruiting up to about
40% of cytosolic GLUT 4 to the plasma membrane, compared to a normal level of 1%.
Glucose uptake can thus be increased 10-40 fold (King & apie, 1998; Sun et al.,
1994). GLUT 1 translocation may also be triggered by insulin (Elsas & Longo, 1992).
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Figure 2.1 Protein kinase B pathway
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While GLUT 1 has a lower affinity, but a higher capacity for glucose than GLUT 4, the
latter is largely responsible for insulin-stimulated glucose uptake, and is far more
efficient than GLUT 1 as a transporter of glucose into the cell (Nishimura et al., 1993).
Inhibitors of Pl3-Kinase have been reported to block the ability of insulin to stimulate
glucose uptake (Cheatham et aL, 1994; Okada et aL, 1994; Quon et al., 1995; Donthi
et al., 2000). Overexpression of active forms of PI3-K at least partially mimic the effect
of insulin (Katagiri et al., 1996; Martin et al., 1996; Tanti et al., 1996; Frevert et al.,
1997), thus providing a link between activation of PKB and the stimulation of GLUT 4
translocation (Kahn et al, 1996; Tanti et al., 1997; Hajduch et al., 1998).
Furthermore, okadaic acid, a potent stimulator of GLUT 4 transport, induces PKB
phosphorylation as efficiently as insulin without the activation of PI3-K. These
observations demonstrate a parallel between the ability of agents to promote GLUT 4
translocation and activate PKB, suggesting an important function for PKB in this
process (Coffer et al., 1998).
2.2.3.2.2.3 Glycogen synthesis
Glycogen synthesis is stimulated by insulin, as well as by increased intracellular
glucose or glucose 6-phosphate (G6P) levels. Glycogen synthase is the most
important enzyme in glycogen synthesis. Two forms of glycogen synthase, one acting
on proglycogen and another on macromolecular glycogen, have been identified
(Alonso et al., 1995), possibly accounting for different rates of synthesis of the different
isoforms of glycogen.
Insulin stimulates glycogen synthesis by increasing glucose uptake and by stimulating
glycogen synthase phosphorylation (Lawrence, 1992). Insulin also inhibits glycogen
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breakdown by promoting dephosphorylation, and thus inactivation, of phosphorylase,
the primary enzyme in glycogen breakdown (King & apie, 1998).
Apart from regulation of glucose-transporter function, insulin stimulation also results in
the phosphorylation and inactivation of glycogen synthase kinase 3 (GSK3) (Coffer et
al., 1998). Stimulation of 293 cells (human embryonic kidney cells) with insulin or IGF-
1 leads to PKB mediated phosphorylation of GSK3 at Ser9, resulting in its inactivation
and consequent activation of glycogen synthesis (Shaw et al., 1997). GSK3 is involved
in several intracellular signaling pathways, including the control of the transcription
factors AP1 and CREB (the cyclic AMP response element binding protein), and the
tumour supressor gene product APC (Welsh et al., 1996).
2.2.3.2.2.4 Glycolysis
Insulin treatment stimulates glycolysis by activating phosphofructose kinase-2 (PFK-2)
via the PKB pathway in rat heart in vivo and in isolated rat cardiomyocytes. PFK-2 is
responsible for generating fructose 2,6-bisphosphate, a key allosteric activator of 6-
phosphofructo-1-kinase, the rate-limiting enzyme in mammalian glycolysis (Deprez et
al., 1997).
2.2.3.2.2.5 Protein synthesis
Insulin contributes to protein synthesis via the PKB pathway. p70S6k plays a key role in
cellular growth control mechanisms by coordinating protein biosynthesis via
phosphorylation of the S6 subunit of 40 S ribosomes or via regulation of the activity of
the eukaryotic initiation factor 4E binding protein, 4E-BP1 (Proud, 1996). Expression of
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activated PKB can stimulate p70S6k activity in T cells, indicating that PKB substrates
are part of the p70S6k activation pathways. Moreover, given the ability of Pl3-Kinase
signals to stimulate PKB and p70S6k, it seems probable that PKB mediates the P13-
kinase activation of p70S6k in Tcells (Reif et al., 1997).
2.2.3.2.2.6 Anti-apoptotic signaling mediated by PKB
It is well known that PKB is involved in the regulation of cell survival (Downward, 1998).
It has been demonstrated previously that inhibition of Pl3-Kinase reduces the ability of
survival factors to protect various cell types from programmed cell death or apoptosis
(Yao and Cooper, 1995; Yao and Cooper, 1996). Jonassen et al. (2000) demonstrated
that in rat neonatal cardiomyocytes, administration of insulin at the onset of
reoxygenation after an ischaemie insult resulted in a significant reduction in total
myocyte cell death and in the development of apoptosis. Their data suggest that a
significant component of the insulin induced cell survival is based on the attenuation of
apoptosis.
The mechanism of PKB protection against programmed cell death has been the
subject of much investigation recently. PKB can phosphorylate the pro-apoptotic Bcl-2
family member BAD (Del Peso et ai, 1997; Datta et al., 1997), both in vitro and in intact
cells. The phosphorylation occurs at Ser136 of BAD (Datta et al., 1997), creating a
binding site for 14-3-3 (a family of ubiquitous highly expressed adaptor proteins).
When BAD binds to 14-3-3 it is unable to heterodimerise with and to inhibit the survival
activity of the proteins Bcl-2 or Bel-XL (Zha et al., 1996). The evidence suggests that
PKB can act to reverse the death-inducing activity of BAD. However, it is far from clear
whether this is the only, or even the primary, way in which the survival signal from PKB
is mediated (Downward, 1998).
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2.2.4 Stress kinases
2.2.4.1 Signaling pathways
Cells respond to extracellular signals by transmitting intracellular instructions to
coordinate appropriate responses. Among the many pathways often used to transduce
these signals are the highly conserved mitogen-activated protein kinase (MAPK) or
extracellular signal regulated protein kinase (ERK) cascades (Robinson & Cobb, 1997).
These cascades are present in all eukaryotic organisms and consist of a three-kinase
module that includes a MAPK, which is activated by a MEK, which in tum is activated
by a MEKK (Cobb & Goldsmith, 1995).
2.2.4.2 p38 MAPK activation by stress
A major advance in understanding signaling events in response to stress came from
the discovery that stresses such as heat shock, protein synthesis inhibitors, UV, and
DNA-damaging agents activate p38 MAPK (Robinson & Cobb, 1997). p38 MAPK may
also be activated by reactive oxygen species (ROS) (Clerk et al. 1998; Aikawa et al.
1997), hypoxia/reoxygenation (Seko et al., 1997), hyperosmotic shock (Clerk et al.,
1998), arsenite and proinflammatory cytokines (Wang et al., 1997). Cells respond to
ischaemia/reperfusion by activating several members of the MAPK family. These
kinases include c-Jun NH2-terminal kinase (JNK), p38 MAPK and the extracellular
signal-regulated kinases (ERK) (Sugden & Clerk, 1998). Studies by Bogoyevitch et al.
(1996) showed that JNK is activated during reperfusion following ischaemia, whilst
ERK is not activated during reperfusion following ischaemia. P38 MAPK and one of its
downstream target substrates, MAPKAPK-2 (MAP kinase activated protein kinase-2),
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are activated during ischaemia and this activation is sustained or increased during
reperfusion (Bogoyevitch et al., 1996; Yin et al., 1995).
Ping et al. (1999) demonstrated that ischaemie preconditioning (PC) (short episodes of
ischaemia) significantly increased the phosphorylation activity of the JNKs and ERKs
via a PKC - dependent signaling pathway. This could be maintained in at least 6
cycles. They also indicated that the phosphorylation activity of the p38 MAPK cascade
was increased by a brief ischaemie stimulus, but the activation was not sustained.
Release of endogenous catecholamines during ischaemia/reperfusion (Sch6mig et al.,
1984) in the extracellular space of the ischaemie myocardium leads to activation of a1-
and ~-adrenergic receptors which, in tum, may result in the stimulation of p38 MAPK,
JNK and ERK. It is known that p38 MAPK is an important downstream target of the
beta-adrenergic signaling pathway via the activation of cAMP and PKA (Cao, 2001).
2.2.4.3 Components of the p38 MAPK signaling pathway (Fig. 2.2)
Similar to stress, G protein-coupled receptor (GPCR) agonists may eventually lead to
the activation of p38 MAPK's. Cellular stresses induce reorganization of the
cytoskeleton and activation of the small GTP-binding proteins, Rae and Cdc-42,
whereas GPCR agonists activate the small GTP-binding protein, Ras, through a PKC-
dependent mechanism. Ras is associated with the activation of the ERK cascade and
may either directly, or indirectly, activate the stress-responsive p38 MAPK. The
upstream activators (MEKK's) of the stress-responsive MKK's have not been clearly
defined but possibly include MEKK's (MAPK or ERK kinase kinases), mixed lineage
kinases (MLK's), and/or p21-activated kinases (pAK's).
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Figure 2.2 p38 MAPK pathway
GPCRagonists STRESSORS (hypoxia, heat
shock, osmotic shock, cytokines
---J---1------
Ras Rac, cdc 42
1
PAK/GCK
1
MEKK MEKK1
1
MEK MKK3/6
1
MAPK p3S MAPK
ATF-2 CHOP MEF-2C MSK1 MAPKAPK-2~
HSP27 (J
Stellenbosch University http://scholar.sun.ac.za
24
In the p38 pathway, the MEKKs activate MKK3 and MKK6 leading to p38 activation
(Sugden & Clerk, 1998).
P38 MAPK has been reported to be located in both the cytosol and the nucleus,
translocating from the cytosol to the nucleus in response to hyperosmotie stimulation
(Raingeaud et al., 1996), or as a consequence of ischaemie stress adaptation (Maulik
et al., 1998).
2.2.4.4 Downstream effects of p38 activation
2.2.4.4.1 Gene expression
The p38 pathway controls the activity of multiple transcription factors and the
expression of many genes (Obata et al., 2000). The pathway leads to phosphorylation
and enhancement of the activity of many transcriptional control factors, including:
• Activating transcription factor (ATF)-1/2 (Raingeaud et al., 1995; Raingeaud et al.,
1996; Degols & Russell, 1997)
• CHOP/GADD153 (growth arrest and DNA damage) (Wang & Ron, 1996)
• MEF-2C (Myocyte enhancer-binding factor 2C) (Han et al., 1997)
• HSF (heat shock transcription factor)-1 (Kim et al., 1997)
• Mnk1/2, which may regulate the activity of the translational initiation factor elF4E
(Fukanaga & Hunter, 1997; Waskiewitz et al., 1997)
Some transcription factors are known to be direct substrates of p38 MAPK, while
others are phosphorylated by downstream protein kinases that are themselves
activated by p38 phosphorylation, such as MAPKAPK-2 (Obata et al., 2000,
Bogoyevitch et al., 1996; Maulik et al., 1996; Zu et aL, 1997)
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2.2.4.4.2 Arachidonic acid signaling
The p38 MAPK pathway also influences the production of arachidonic acid metabolites
(e.g., prostaglandins, leukotrienes, and other eicosanoids). The activation of
Phospholipase A2 (PLA2), a primary regulator of arachidonic release from
phospholipids, is enhanced via p38 MAPK-dependent phosphorylation upon TNF-a
treatment of neutrophils (Waterman et al., 1996) or endothelin-1 treatment of smooth
muscle cells (Husain & Abdel-Latif, 1999). After its release, arachidonate is
metabolized via two main pathways, the cyclooxygenase (COX) and lipooxegenase
pathways, that are largely constitutively active (Obata, 2000). The activity of the COX
pathway is increased as a consequence of the gene expression of the first enzyme in
the pathway, COX-2, a process that can be enhanced by p38 activity (Guan et al.,
1998; Hwang et al., 1997; Pouliot et al., 1997). This should lead to increased
production of prostaglandins at the expense of leukotriene generation, leading to
selective enhancement or suppression of particular inflammatory responses (Obata et
al.,2000).
2.2.4.4.3 Cytokine signaling
In addition to its recognized role in TNF-a and IL-1 production (Lee et al., 1994), p38
MAPK also plays a role in the production of IL-4 (Schafer et al., 1999), IL-6 (Beyaert et
al., 1996), IL-8 (Marie et al., 1999), and IL-12 (Lu et al., 1999).
2.2.4.4.4 Nitric oxide signaling
The p38 MAPK pathway can enhance nitric oxide production by increasing the
intracellular concentration of arginine, the substrate for nitric oxide synthetase via
Stellenbosch University http://scholar.sun.ac.za
26
stimulation of arginine transporter activity (Caivano, 1998). It is also required for
increased gene expression of the inducible form of NO synthetase (iNOS, NOS II)
(Guan et al., 1997). P38 may also be involved in the transduction of nitric oxide
signaling. Activation of p38 MAPK in human neutraphils following LPS stimulation is
attenuated by inhibitors of NO synthetase and by NO scavengers whereas treatment
with NO releasing agents increased MKK3 and MKK6 activity and p38 phosphorylation
(Browning et al., 1999). P38 is furthermore required for the NO-induced apoptosis in a
neutrophil-like cell line (HL60) (Jun et at., 1999).
2.2.4.4.5 Cytoskeletal dynamics
Several cytoskeletal proteins are substrates of the p38 pathway, including the
microtubule-associated protein tau (Goedert et al., 1997), the actin-associated protein,
heat shock protein - 27 (hsp27), and the intermediate filament proteins h-caldesmon
(Hedges et al., 1998), vimentin (Cheng and Lai, 1998) and keratin polypeptides 8,18
(Feng et al., 1999). The significance of most of these p38-catalyzed phosphorylations
is unclear, but the effect of hsp27 phosphorylation has been extensively examined.
After cells are exposed to hyperthermia, hsp27 levels increase and contribute to
thermo resistance in a p38-dependent manner, likely through influencing actin
reorganization (Landry & Huot, 1995; Lavoie et al., 1993). Under nonstress conditions,
hsp27 forms large oligomers that, together with hsp70, act as molecular chaperones to
stabilize and refold various proteins. Activation of p38 MAPK induces the
phosphorylation of the small heat shock protein, hsp27 via MAPKAPK-2, causing a
reduction in the size of hsp27 oligomers. These smaller oligomers are thought to be
responsible for the stabilization of actin filaments (Lavoie et al., 1993).
Stellenbosch University http://scholar.sun.ac.za
27
2.3 Protective vs. deleterious effects of p38 MAPK stimulation
Controversy surrounds the ultimate role of p38 MAPK in myocardial
ischaemia/reperfusion. Activated p38 MAPK may contribute to signal transduction
pathways that culminate in cell death following stress, or they may act to prevent
widespread cell death, limit damage or mediate adaptation (Bogoyevitch, 2000).
Studies conducted by Mackay and co-workers (Mackay & Mochly-Rosen, 1999), using
chemical inhibitors, concluded that p38 MAPKs promote cardiac myocyte death during
extended periods of ischaemia or exposure to hydrogen peroxide.
Marais et al. (2000) investigated the effect of preconditioning (PC) on the activation of
p38 MAPK during 25 minutes sustained global ischaemia, and they noted that p38
MAPK was activated after 5 minutes of ischaemia in their perfusion protocol. Their
findings indicated that the attenuation of p38 MAPK activity during sustained ischaemia
and reperfusion was associated with improved functional recovery. They also showed
that inhibition of p38 MAPK activation with SB 203580 could significantly improve both
cell morphology and viability.
Saurin and his co-workers (2000) investigated the isoform selectivity of p38 MAPK by
infecting myocytes with adenoviruses encoding wild-type p38u or_p38f3 MAPK. They
found that cells expressing a dominant negative p38u, which prevented ischaemie p38
MAPK activation, were resistant to lethal simulated ischaemia. Thus inhibition of p38u
MAPK activation during ischaemia reduced injury.
Supporting these findings, Ma et al. (1999), concluded that p38 MAPK plays a pivotal
role in promoting myocardial apoptosis in isolated perfused rat hearts. Similarly,
cardiac injury in response to oxidative stress induced by hydrogen peroxide was
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apparently mediated by a p38 MAPK-dependent production of TNF-u (Meldrum et aL,
1999).
Cardioprotection may therefore be correlated with the ability of a compound or
intervention to inhibit p38 MAPK activation (Bogoyevitch, 2000).
On the other hand Wang and co-workers (Wang et al., 1998) yielded more complex
results by the overexpression of MAPK. Whilst p38 MAPK have been implicated in the
survival response of cardiac myocytes, it may be the p38a. MAPK isoform that is
specifically involved in cell death. The results of overexpression of p38 MAPKs and
constitutively - activated mutants of their specific activators, MKK3 and MKK6 indicate
that this pathway plays a complex role in the cardiac myocyte. Whilst the
overexpression of MKK3 or MKK6 increased surface area sarcomeric organisation and
ANF expression, the co-expression of MKK3 with p38a. MAPK prevented these
changes and induced cell death. In contrast, p38J3MAPK expression in the presence
of MKK3 augmented hypertrophy and promoted cell survival (Wang et al., 1998). Thus
p38a. MAPK apparently promotes cell death whilst p38J3 MAPK promotes cell
hypertrophy and survival. (Saurin et al., 2000)
The effects of the different p38 MAPK isoforms are therefore likely to be complex and
dependent on stimulus and cellular context. The extent of activation of the different
isoforms of p38 MAPK may dictate whether a cardiac myocyte is committed to death or
survival (Nagarkatti & Sha'afi, 1998).
Further investigation to identify whether and how p38 MAPK might protect the
myocardium (or whether it is good or bad) is important to resolve this controversy.
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The focus of this study was therefore to examine the responses of the second
messengers (PKB, p38 MAPK & cAMP) to insulin, and to correlate their respective
activities with the functional parameters as a measure of cardiac performance.
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Chapter 3
MATERIALS AND METHODS
3.1 Animals
Male Wistar rats weighing between 280g - 350g were used. The rats had free access
to food (standard lab chow) and water. They were maintained in animal quarters at a
constant temperature (22°C) and humidity (40%) and were exposed to a twelve-hour
artificial light cycle. This investigation conforms to the "Guide for the care and use of
laboratory animals" published by the US National Institutes of Health (NIH publication no
85-23, revised 1985). The project was given ethical clearance by the Sub Committee C
of the University of Stellenbosch (animal ethics clearance number - 95\103).
3.2 Perfusion technique
The rats were anaesthetized by an intraperitoneal injection of Intramed Thiopentone
sodium (sodium pentobarbital) 0,1mg/g. The hearts were quickly excised and arrested
in ice cold Krebs - Henseleit solution containing 119 mM NaCI, 25 mM NaHC03, 4.7
mM KCI, 1.2 mM KH2P04, 0.59 mM MgS04.7H20, 0.59 mM Na2S04, 1.25 mM
CaCI2.2H20 and 5mM glucose. The solution was aerated with 95% O2; 5% CO2 to
maintain the pH at 7.4. The isolated hearts were then mounted on a cannula via the
aorta and perfused with Krebs - Henseleit buffer (KH) (37°C) within 60 seconds of
excision. The hearts were subsequently freed of excess non-cardiac tissue. All hearts
were perfused retrogradely in accordance with the Langendorff technique. A Sarns
Model 5500 pump kept the meniscus of the buffer at a constant level so as to maintain a
perfusion pressure of 100cm H20. The myocardial temperature of 37°C was maintained
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throughout the experiment by means of aThermomix 1460 waterbath, which circulated
warm water through the water-jacketed glass reservoirs. A thermistor probe was
inserted into the right coronary sinus to monitor myocardial temperature during
ischaemia.
The variation in systolic and diastolic pressure was monitored through the insertion of a
compliant balloon into the left ventricle. The balloon was made of plasticised PVC and
inflated with distilled water to establish a baseline pressure of 4-10mmHg. The balloon's
volume and the baseline pressure, was maintained throughout the experiment. Any
displacement of water, caused by the contraction of the heart against the balloon, was
converted to a pressure reading by a pressure transducer and recorded on a Multitrace
2 chart recorder.
Global ischaemia was induced by reducing the coronary flow rate from 8-15 ml/min to
0,2 ml/min, by using a Gilson Minipuls 2 peristaltic pump.
3.3 Preliminary perfusion protocol (Figure 3.1)
In order to determine the optimum time of administion of insulin to the buffer to achieve
its ultimate cardioprotective effect, insulin (0,3 IlIU/ml) was added to the buffer in one
group during reperfusion only (glu + insrep), and in the other group, insulin was added
throughout the entire experiment (glu + ins).
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Figure 3.1 Preliminary perfusion protocol
A) glucose (5mM) throughout experiment + insulin (0,3 f.!IU/ml) added only during
reperfusion (glu + insrep).
o 15 30 45 60 65 75 90 min
* * * * *
B) glucose (5mM) + insulin (0,3 f.!IU/ml) throughout the experiment (glu + ins)
Stabi lization Ischaemia Reperfusion
o 15 30 45 60 65 75 90min
* * * * * *
3.4 Perfusion protocol (Figure 3.2)
The protocol consisted of three sequential periods lasting 30 minutes each: (excluding
control group: group 1)
1.) 0 - 30 min.: During the stabilization phase hearts were perfused under standard
conditions at a pressure of 100 cm H20 (coronary flow = 8-15 mi/min.).
2.) 30 - 60 min.: The hearts were subjected to global low flow ischaemia (0,2 ml/min).
The myocardial temperature was kept between 36,8 "C and 37,3 °C.
3.) 60 - 90 min.: During the reperfusion phase, hearts were reperfused under standard
conditions at a pressure of 100cm H20.
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Five different groups were used:
(a) Group 1: 90 minutes of perfusion under standard control conditions at a pressure of
100 cm H20. Group 1(a) were perfused with a perfusion solution containing 5 mM
glucose (n=4 hearts per group), while Group 1(b) were perfused with a perfusion
solution containing 5 mM glucose and 0,3 ~IU/ml insulin (n=4 hearts per group).
For the purpose of biochemical analysis, hearts were freeze-clamped at t= 10, 30
and 90 minutes. (n=4 hearts per group)
(b) Group 2: Perfusion solution containing 5 mM glucose. Hearts were subjected to
ischaemia and reperfusion. For biochemical analysis, hearts were freeze-clamped
at t= 30,45,60, 65, 75, and 90 minutes. (n=6 hearts per group)
(c) Group 3: Perfusion solution contained 5 mM glucose + 0,3 ~IU/ml insulin throughout
the experiment. Hearts were subjected to ischaemia and reperfusion. Hearts were
freeze-clamped at t= 30, 45, 60, 65, 75, and 90 minutes for the purpose of
biochemical analysis. (n=6 hearts per group)
(d) Group 4: Perfusion solution containing 5mM glucose + 0,3 ~IUlml insulin throughout
the experiment with wortmannin (100nM) (red block) present during ischaemia (30-
60 min). Wortmannin is a phosphatidylinositol 3-kinase inhibitor, and consequently
will inhibit PKB activation. Hearts were freeze-clamped at 60 min for biochemical
analysis. (n=4 hearts per group)
(e) Group 5: Perfusion solution containing 5mM glucose and 0,3 ~IU/ml insulin
throughout the experiment, with wortmannin (red block) added during reperfusion
(time 60 - 90 min). Hearts were freeze-clamped at 90 min (end of reperfusion).
(n=4)
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Figure 3.2 Perfusion protocol
* ~ Mechanical function
o ~ Freeze clampingA) Group l(a), (b): glucose (5rnM)± insulin (0,3!-lID/ml)L- ---'
* *
75
*
90mino 10 15 30 45 60 65
* *
o o o
B) Group 2: glucose (5 mM)
o 15 30 45 60 65 75 90min
* * * * *
o o o o o o
C) Group 3: glucose (5rnM)+ insulin (0,3 !-lID/ml)
o 15 30 45 60 65 75 90min
* * * * *
o o o o o o
D) Group 4: glucose (5rnM) + insulin (0,3 !-lID/ml)+ wortmannin (100nM), time 30-60 min
Reperfusion
o 15 30 45 60 65 75 90min
* * * * *
o
E) Group 5: glucose (5rnM)+ insulin (0,3 !-lID/ml)+ wortmannin (100nM), time 60-90 min
o 15 30 45 60 65 75 90min
* * * * *
o
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3.5 Measured variables
In order to compare the functional recovery of the hearts in the different groups, the
heart rate (beats/min), coronary flow (ml/min), left ventricular developed pressure
(mmHg), and temperature (OC)were monitored at t = 15, 3D, 65, 75, and 90 min.
Coronary flow (ml/min) was measured by manually collecting the volume of the heart's
effluent in one minute.
Functional recovery, as indicated by the left ventricular developed pressure (LVOP) at
the end of the reperfusion period, was expressed as a percentage of the pre-ischaemie
LVOP after 30 minutes of perfusion.
The rate pressure product (RPP) was calculated by multiplying the heart rate and the
LVOPo The percentage rate pressure product recovery (%RPP) was reperfusion RPP
expressed as a percentage of the pre-ischaemie RPP after 30 min of stabilization.
The time to onset of ischaemie contracture (TOIC) was determined by measuring the
time from the beginning of ischaemia until a 4 mmHg rise in the left ventricular diastolic
pressure was observed.
3.6 Exclusion criteria
Hearts with coronary flow rates outside the range of 8 - 15 ml/min, and heart rates
outside of 200 - 340 beats/min during the stabilization phase, were excluded.
3.7 Tissue samples
For the purpose of biochemical analysis, hearts were freeze-clamped with Wollenberger
metal thongs, which were pre-cooled in liquid nitrogen. The freeze-clamped ventricular
tissue was then stored in liquid nitrogen (N2) until analyzed.
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3.8 Biochemical analysis
3.8.1 cAMP evaluation
0.1 gram of the ventricular tissue was fully pulverised in a pre-cooled metal
homogenizer. The tissue was extracted with 1.2 ml 6% perchloric acid (PCA) in
Greyward tubes on ice. All samples were kept on ice for 2 hours with occasional
vortexing. After centrifugation for 20 minutes at 4000 rpm, 1 ml of the supernatant was
transferred to an Eppendorff tube containing 5J..L1universal indicator. Each tube was
neutralised with a KOH-Tris mixture (two parts 40% KOH-saturated KCL; three parts 0.2
M Tris-HCI, pH 7.5 [4°C]). The neutralisation volume was recorded and the samples left
on ice to fully precipitate. Cyclic AMP levels were determined by Amersham's
radioimmune assay (Amersham International pic, Amersham, UK). A standard curve
ranging between 0.125 - 16 picomoles was included. Values obtained were presented
as picornoles/g wet weight.
3.8.2 Western blotting for p38 mitogen activated protein kinases (MAPK) and
Protein kinase B (PKB)
Cytosolic p38 MAPK was determined by homogenizing freeze-clamped hearts with a
lysis buffer containing (in mM): Tris 20; p-nitrophenylphosphate 20; EGTA 1; NaF 50;
sodium orthovanadate 0.1; phenyl methyl sulphonyl fluoride (PMSF) 1; dithiotreitol (OTT)
1; aprotinin 10 J..Lg/ml;eupeptin 10 J..Lg/ml,pH 7.4. For PKB, a lysis buffer containing (in
mM): Tris-HCI (pH7.4) 20; NaCI 25; EGTA 1; NaF 10; sodium ortovanadate 1;
phenylmethyl sulphonyl fluoride (PMSF) 0.1; Benzamidine 1; 1% Triton-X 100; aprotinin
10 J..Lg/rnl;leupeptin 10 J..Lg/mlwas used.
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The homogenates were spun down in a microfuge at 4°C for 15 minutes to remove
particulate matter. The supematant protein content was determined using the Bradford
technique (Bradford, 1976). The supematants were diluted in laemmli sample buffer,
boiled for 5 min. and 20 J..lgprotein was separated by electrophoresis on a 12%
polyacrylamide gel, using the standard Bio-RAD Mini-PROTEAN II system. The
separated proteins were transferred to a PVDF (polivinylidene fluoride) membrane
(Immobilon™-P, from Millipore). These membranes were stained with Ponceau S red
(reversible stain) to visualize the proteins, and to assess the quality and quantity of the
transfer. The membranes were laser-scanned and densitometrically analyzed (UN-
SCAN-IT, Silkscience).
Non-specific binding sites on the membranes were blocked with 5% fat-free milk in Tris-
buffered saline, 0.1% Tween-20 (TBST). The activated p38 MAPK was visualized with
an appropriate primary antibody (phospho-p38 MAPK [Thr 180fTyr 182] Antibody, New
England Biolabs) directed against the dual-phosphorylated, therefore activated enzyme.
The activated PKB was visualized with phospho-Akt [Ser 473] antibody (New England
Biolabs). Membranes were washed with large volumes of TBST (5 x 5 min.) and the
immobilized primary antibody conjugated with a diluted horseradish peroxidase-labelled
secondary antibody (purchased from Amersham LIFE SCIENCE). After thorough
washing with TBST, membranes were covered with ECl ™ detection reagents and
quickly exposed to an autoradiography film (Hyperfilm ECl, RPN 2103) to detect light
emission through a non-radioactive method (ECl ™ Westem blotting from Amersham
Pharmacia Biotech). Films were densitometrically analyzed, as described above.
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3.8 Chemicals
All chemicals used for buffers were purchased from BDH or Merck, analytical grade,
unless otherwise indicated. The insulin (Humulin N) was obtained from Eli Lilly SA,
(Fregersheim, France). The wortmannin was obtained from Sigma Chemicals Co.
3.9 Statistical analysis
Values are expressed as mean ± standard error of the mean (SEM). Results were
compared using a one-way ANOVA with Bonferroni Multiple Comparison as post test.
P-values less than 0.05 (P<0.05) was considered as significant.
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Chapter 4
RESULTS
4.1 Preliminary study
4.1.1 Left ventricular developed pressure (LVDP) glu+insrep vs. glu+ins
(Figure 4.1)
Five minutes after reperfusion, the glu+ins group showed significant improvement
compared to the glu+insrep group, with a LVDP of 83.9±4.6 mmHg vs. 47.4±9.1
mmHg (P<0.001). LVDP of the glu+ins group maintained reperfusion pressures
from 5 min reperfusion to 30 min reperfusion, whilst the LVDP in the glu+insrep
group improved from 47.4±7.5 mmHg to 65.1±5.6 mmHg.
Our results suggest that insulin administration throughout the protocol resulted in
improved recovery.
4.1.1 Effect of insulin on control hearts (Figure 4.2)
Results presented in Figure 3.2 showed that insulin administration significantly
improved LVDP in normoxic conditions, showing that insulin had a positive inotropic
effect.
4.2 Functional data
4.2.1 Heart rate (Figure 4.3)
At the end of the stabilization period the HR for group 3 was 275.8±3.4 beats/min
compared to 274.1 ±4.9 beats/min for group 2. During ischaemia heart rates were
not measured. No statistical differences in reperfusion HR could be detected.
There was therefore no significant difference in HR between the two groups.
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4.2.2 Coronary flow (Figure 4.4)
Pre-ischaemie coronary flow (CF) was 11.3±O.3 ml/min for group 2 and 11.9±O.2
ml/min for group 3 at the end of the stabilization phase. During ischaemia, the CF
was fixed at 0.2 ml/min. After 5 min and 15 min of reperfusion, there was a
significant difference between the CF of the two groups (P<0.001). Group 3
retumed to pre-ischaemie values (10.6±0.6 ml/min), while group 2 reached only
7.7±0.5 ml/min).
At the end of reperfusion, the CF of group 3 remained high at 9.5±0.7 ml/min
compared to group 2 at 7.4±0.6 ml/min. There was no significant difference in CF
between the two groups at this point.
4.2.3 Left ventricular developed pressure (LVDP) (Figure 4.5)
During the pre-ischaemie phase, LVDP was similar in both groups at 113.4±1.7
mmHg and 105.7±1.6 mmHg after 30 minutes of stabilization. After 5 minutes of
reperfusion, group 3 showed significantly improved LVDP compared to group 2
(83.92±4.6 vs. 31.7±4.5 mmHg) (P<0.001). During the rest of the reperfusion
phase, the developed pressure of group 3 remained significantly higher than that of
group 2 at 84.4±5.2 mmHg and 46.2±7.4 mmHg respectively after 15 minutes and
86±3.9 mmHg and 44.7±7.04 mmHg at the end of reperfusion. (P<0.001)
4.2.4 Percentage recovery of left ventricular developed pressure (LVDP)
(Figure 4.6)
The LVDP recovery of the hearts in group 3 was significantly higher than that of
group 2 throughout the entire reperfusion period (P<0.001). After 5 minutes of
reperfusion, group 3 recovered to 80.2±3.9% of pre-ischaemie values compared to
27.8±4.8% of those hearts in group 2. These values remained similar after 15
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minutes of reperfusion (group 3 - 83.2±5.7 vs. group 2 - 37.3±7.0%), and at the end
of reperfusion (group 3 85.5±4.6 compared to 44.8±4.9% of group 2).
4.2.5 Rate pressure product (RPP) (Figure 4.7)
The pre-ischaemie RPP for both groups were similar after 15 minutes of
stabilization (group 3 - 30920±510.3 vs. group 2 - 28680±523.2), and remained
constant throughout 30 minutes of stabilization (group 3 - 31340±522.1 vs. group 2 -
28590±578.2). The reperfusion RPP after 5 minutes for group 3 were significantly
higher (20430±1448) than the values of group 2 (13010±2029), (P<0.001). The
RPP of group 3 remained significantly higher (P<0.001) after 15 minutes of
reperfusion (group 3 - 22820±1271 vs. group 2 - 9036±1628), and at the end of
reperfusion with group 3 - 21450±1444 vs. group 2 - 8608±1828.
4.2.6 Percentage rate pressure product recovery (%RPP) (Figure 4.8)
Insulin treated hearts (group 3) showed reperfusion recoveries of 68±4.6% to the
pre-ischaemie values compared to 44.6±5.4% of non-insulin treated hearts (group
2), (P< 0.001). In group 3, RPP values remained similar after 15 minutes of
reperfusion (group 3 - 75.3±5.9%), while the RPP of group 2 increased only slightly
to 37.8±6.5%. The significant difference between the insulin treated and non-insulin
treated hearts persisted to the end of reperfusion (P<0.01).
4.2.7 Time to onset of ischaemie contracture (Figure 4.9)
Ischaemie contracture was significantly delayed in the presence of insulin (group 3 -
16.7±1.2 min) compared to 9.9±0.7 min (group 2) where insulin was not present,
(P<0,0001 ).
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4.2.8 Effect of wortmannin on LVDP (Figure 4.10 + Figure 4.11)
In the absense of insulin, administration of wortmann in had no effect on the
reperfusion LVDP (Figure 4.10). The aim of the next experiment was to investigate
the effect of wortmannin on the LVDP when added either before ischaemia or at the
onset of reperfusion to a perfusion solution containing 5mM glucose and 0,3 IJ.IU/ml
insulin (Figure 4.11). After 5 minutes of reperfusion, the LVDP of group 3 was
83,9±4.6 mmHg with the LVDP of group 4 and group 5 significantly lower at 17±6.5
mmHg and 13±4.2 mmHg respectively (P<0.0001). After 15 minutes of reperfusion,
the LVDP of group 4 and group 5 remained the same at 14±3.6 and 26.5±11.3; still
significantly lower than that of group 3 (84.4±5.2). The conditions at the end of
reperfusion remained similar with the LVDP of group 4 (33.5±9.6 mmHg) and group
5 (17.5±5.1 mmHg) significantly lower than the LVDP of group 3 at 86.0±3.9
(P<0.0001). This indicates that PI3-K may playa role in the protective effect of
insulin.
4.3 Biochemical data
4.3.1 cAMP (Figure 4.12)
At the end of the stabilization phase, the myocardial cAMP levels of group 2 and
group 3 were in the same range at 286.1 ±23.9 pmol\gwwt (picomole per gram wet
weight) and 295.5±28.7 pmol/gwwt respectively. After 15 minutes of ischaemia,
these values were elevated to 463.9±29.7 pmol/gwwt and 434.0±29.5 pmol/gwwt
respectively. At the end of ischaemia, cAMP levels in group 2 were reduced to
326.6±35.8 pmollgwwt, while that of group 3 were increased significantly to
639.6±27.3 pmollgwwt (P<0,001). When wortmannin was added during ischaemia
the rise in cAMP was abolished, and therefore group 4 presented similar values as
group 2 (332.8±15 pmol/gwwt). After 5 minutes of reperfusion, cAMP levels in
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group 3 decreased to the levels of group 2 (360.9±45.1 vs. 338.4±27.9 pmol\gwwt).
After 15 minutes of reperfusion, cAMP levels for group 2 and group 3 were similar
(273.2±32.5 and 266.4±14.5 pmol\gwwt respectively), but dropped even more after
30 min of reperfusion. Addition of Wortmannin during reperfusion only (group 5) did
not alter the levels of cAMP at the end of reperfusion.
4.3.2 p38 MAPK activation (Figure 4.13 & Figure 4.14)
After 30 minutes of perfusion, the amount of p38 MAPK activated in group 2 was
significantly higher than that of group 3 at 50±15 arbitrary densitometric units (adu)
vs. 30±2.6 adu (P<0.05). In the latter group, 15 minutes of ischaemia, elevated
activated p38 MAPK levels to 45±8.5 adu, while levels in group 2 remained constant
at 50±5 adu. This activation was transient because activated p38 MAPK levels
decreased in both groups at the end of 30 minutes ischaemia,. (25±2.7 and 15±3
adu, respectively). Addition of wortmannin before ischaemia did not alter p38
MAPK levels (30.3±5.5 adu) at the end of ischaemia (group 4). Five minutes of
reperfusion resulted in a significant activation of p38 MAPK in group 2 but not in
group 3 (55±5 adu vs. 30±5.3 adu),(P<0.05). However, after 15 min of reperfusion
the activation of p38 MAPK did not differ significantly between groups 2 and 3. At
the end of reperfusion, however, levels of activated p38 MAPK in group 3 dropped
to 15±3.8 adu, while it remained significantly higher in group 2 (55±3.0) (P<0.05).
Wortmannin added at the onset of reperfusion (group 5) could partially abolish the
effects of insulin to suppress p38 MAPK activation after 30 min of reperfusion.
Figure 4.14 is the representative Westem blot of the activated p38 MAPK in insulin
vs. non-insulin treated hearts.
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4.3.3 PKB activation (Figure 4.15 & Figure 4.16)
As insulin is known to activate PKB, the expected elevated levels of phosphorylated
PKB were recorded in hearts from group 3. This was significantly higher than the
group 2 levels at the end of the stabilization phase at 30±9 vs. 5±O.5 adu
(P<0.0001). This remained similar during the first 15 minutes of ischaemia. This
PKB activity was depressed by 30 min of ischaemia as group 2 had zero activated
PKB at the end of the ischaemie period, while group 3 levels dropped to 5±2.1 adu.
The known inhibitor for PI3-kinase, wortmannin, when added before induction of
ischaemia did not further lower this. The presence of insulin in group 3 resulted in
occurrence of strong PKB activation during reperfusion, peaking at 15 minutes
(50±11.1 adu) and diminishing at 30 minutes (15±3 adu). Reperfusion had no
effect on PKB activation in group 2. Wortmannin added at the onset of reperfusion
abolished PKB activity measured at 30 min reperfusion (group 5 vs. group 3).
Figure 4.16 is the representative Western blot of activated PKB in insulin vs. non-
insulin treated hearts.
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Chapter 4 - Addendum
FiQure 4.1: Preliminary insulin trial
140
120- ..-------- -----W"en 100 TX *E 80 .---------.---- __-------'i'E i T_ __.-D- eo r:Q 40~ 20 Pre-ischaemia Ischaemia0
0 10 20 30 40 50 60 70 80 90 100
time (min)
I--+--glu+ins (rep) - --.---- glu+ins I
LVDPof hearts perfused with 5mM glucose and 0,3
plU/mi insulin added either throughout the experiment
{glu+ins}, or only during reperfusion {glu+ins(repJ}.
n=4 hearts per group.
* P<0.001 for {glu+ins} vs. {glu+ins(repJ}
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Figure 4.2: Effect of insulin on control hearts
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time (min)
!--+-group 1(a) ----.---- group1(b)!
LVDPof control healts. Healts from group 1were divided
into two groups: KH perfusion solution of group 1(a)
contained 5mM glucose, while 5mM glucose and 0,3plU/mi
insulin were added to the KH of group 1(b). Hearts were
perfused under normal conditions - no ischaemia.
n=4 healts per group
* P< 0.001group 1(a) vs. group 1(b).
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Figure 4.3: Heart rate
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I-+--group 2 ----.---- group3)
HR of hearts perfused with standard KH solution containing
either 5mM glucose (group 2) or 5mM glucose and 0,3 plU/mi
insulin (group 3).
n=6 hearts per group.
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Figure 4.4:Coronary flow
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CF of hearts perfused with standard KH solution containing
either 5mM glucose (group 2), or 5mM glucose and 0,3plU/mi
insulin (group 3)n=6 hearts per group.
* P<0.OO1vs. group 2.
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Figure 4.5: Left ventricular developed pressure
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Figure 4.6: % LVDP recovery
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Figure 4.7: Rate pressure product
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RPP of hearts perfused with standard KH solution containing
either 5mM glucose (group 2) or 5mM glucose and 0,3plU/mi
insulin (group 3). The rate pressure product (RPP) was
calculated by multiplying the heart rate and the LVOP.
n=6 hearts per group.
* P<0.001 vs. group 2.
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Figure 4.8: %RPP recovery
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insulin (group 3). The percentage rate pressure product
recovery (%RPP) was expressed as a percentage of the pre-
ischaemie RPP after 30 min of stabilization.
n=6 hearts per group.
* P<0.001; ** P<0.01 vs. group 2.
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Figure 4.9: Time to onset of ischaemie contracture
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Time to onset of ischaemie contracture of hearts perfused with
standard KH solution containing either 5mM glucose (group 2) or
5mM glucose and 0,3plU/mi insulin (group 3).
The time to onset of ischaemie contracture (TOIC) was
determined by measuring the time from the beginning of
ischaemia until a 4 mmHg rise in the left ventricular diastolic pressure was
observed.
n=6 hearts per group.
* P<0.001 vs. group 2.
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Figure 4.10: Effect of wortmannin on LVDP
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LVDP of hearts perfused with standard KH solution containing
either 5mM glucose (group 2) or 5mM glucose and 100nm
wortmannin (group 2 + wort).
n=6 hearts per group
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Figure 4.11: Effect of wortmannin on LVDP
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LVDPof hearts perfused with standard KH solution
containing:
(a) 5mM glucose and 0,3 plU/mi insulin (group 3),
(b) 5mM glucose, 0,3 plU/mi insulin and 100nm wortmannin
added during ischaemia (group 4)
(c) 5mM glucose, 0,3plU/mi insulin and 100nm wortmannin
added during reperfusion (group 5) n= 6 hearts per group
* P< 0.001between group 3 vs. group 4 and 5.
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Figure 4.12: cAMP
cAMP
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cAMP activation of hearts perfused with standard KH solution
containing:
(a) 5mM glucose (group 2),
(b) 5mM glucose and 0,3 jilU/ml insulin (group 3),
(c) 5mM glucose, 0,3 jilU/ml insulin and 100nm wortmannin
added during ischaemia (group 4)
(d) 5mM glucose, 0,3 jilU/ml insulin and 100 nm
wortmannin added during reperfusion (group 5)
cAMP activation was determined as described in Materials and Methods.
n=6 hearts per group.
+ P<0.02; * P<0.001
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Figure 4.13: p38 MAPK
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Activated p38 MAPK of hearts perfused with standard KH solution
containing:
(a) 5mM glucose (group 2)
(b) 5mAf glucose and 0,3 f.llU/ml insulin (group 3),
(c) 5mM glucose, 0,3 f.llU/ml insulin and 100 nm wortmannin added
during ischaemia (group 4)
(d) 5mAf glucose, 0,3 f.llU/ml insulin and 100 nm wortmannin added
during reperfusion (group 5)The activated p38 was visualized with
an appropriate primary antibody (phospho-p38 AfAPK
[Thr 180ITyr 182] directed against the dual-phosphorylated,
activated enzyme.
n=6 hearts per group
-+ P<0.02; * P<0.001
Stellenbosch University http://scholar.sun.ac.za
58
Figure 4.14: Representative Western blot of p38 MAPK activation of
hearts perfused with standard KH solution containing:
(a) 5mM glucose (group 2)
(b) 5mM glucose and 0,3plU/mi insulin (group 3)
I or·. I < m I. < "'" (a)
30' Con 15' Isc 30' Isc 5' Rep 15' Rep 30' Rep
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Figure 4.15: Protein kinase B (PKB)
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PKB activation of hearts perfused with standard KH solution
containing:
(a) 5mM glucose,
(b) 5mM glucose and 0,3plU/mi insulin (group 3),
(c) 5mM glucose, 0,3 plU/mi insulin and 100nm wortmetmin added
during ischaemia (group 4)
(d) 5mMglucose, 0,3 plU/mi insulin and 100nm worlmannin added
during reperfusion (group 5)
The activated PKB was visualized with an appropriate primary
phospho-Akt {Ser 473Jantibody.
n=6 hearts per group.
# P<0.02; * P<0.001
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Figure 4.16: Representative Western blot of PKB activation of
hearts perfused with
standard KH solution containing:
(a) 5mM glucose (group 2)
(b) 5mM glucose and 0,3plU/mi insulin (group 3).
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Chapter 5
DISCUSSION
It is well documented that insulin protects the heart against ischaemia. Pioneering work
on the cardioprotective effect of insulin against ischaemia was performed by Sodi-
Pallares in 1962, and sparked the interest in this field of study. The positive effect of
insulin on the functional recovery and survival of the ischaemie heart has been the focus
of several studies. Amongst the major findings are the improved cardiac output recovery
during reperfusion (Van Rooyen et at., 1998), a reduction in infarct size with insulin
given at the onset of reperfusion (Jonassen et al., 1996), and the attenuation of
apoptosis in rat neonatal cardiomyocytes when insulin is administered during
reoxygenation (Jonassen et al., 2000).
For long it was believed that the protective effects of insulin, such as the
(a) Recruitment of glucose transporters to enhance glucose entry (Coffer et al., 1998),
(b) Stimulation of glycolysis (Deprez et at., 1997),
(c) Enhancement of glycogen synthesis (Lawrence, 1992),
(d) Improved protein synthesis (Reif et al., 1997), and
(e) Positive inotropic and positive chronotropic properties (Kearney et al., 1998) were
metabolic of origin, but lately the emphasis shifted towards the diverse effects of signal
transduction pathways elicited by insulin e.g. the different kinase cascades. Although
these beneficial effects of insulin on ischaemia/reperfusion induced injury are well
known, the precise mechanism by which insulin produces these effects are still not clear.
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This study was therefore designed to investigate the possible roles for cAMP, PKB and
p38 MAPK in the cardioprotection offered by insulin in the reperfused, ischaemie
myocardium.
5.1 Preliminary study
5.1.1 Perfusion protocol
In order to resolve the protocol that best elicits the beneficial effects of insulin on the
heart, we performed a preliminary study to determine the optimal time of administration
to the perfusion solution. In a study conducted by Jonassen and co-workers, they
concluded that glucose-insulin-potassium (GIK) administered at the onset of the
pastischemie reperfusion period was as cardioprotective as the administration of GIK
during the entire ischemiaJreperfusion period (Jonassen, 2000). We wanted to examine
whether this was also true in our model using insulin in conjunction with low glucose
(SmM), or if insulin was able to exert a protective effect even before stressful events,
and thus 'prepare' the hearts to better withstand the consequences of ischaemia and
reperfusion. We therefore, added insulin to the perfusion solution only during the
reperfusion period in one group, and throughout the entire experiment in the other
group. (Figure 4.1). On the basis of our results, insulin was added to the perfusion
solution in all subsequent experiments in groups that were treated with insulin.
5.1.2 Effects of insulin on LVDP.
We observed that insulin increased the LVDP significantly under control conditions
(Figure 4.2). This can be attributed to the positive inotropic ability of insulin that allows
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improved contraction of the myocardium (Keamey et al., 1998), and thus a better
developed pressure. Addition of insulin in vitro to bovine and rat hearts stimulates
Na+/Ca+exchange function (Kato & Kako, 1988). In isolated human atrial myocytes, the
addition of insulin stimulates the Ca2+ current (Maier et al., 1999). Higher calcium stores
and increased Na+/H+ antiport activity as a result of the addition of insulin enhance
muscular performance and thus provide a crucial survival element (Aviv, 1994). These
effects explain the positive inotropic effects of insulin.
5.2 The effect of ischaemia and reperfusion
5.2.1 Heart rate
Heart rates of both the insulin treated hearts (group 3) and non-insulin treated hearts
(group 2) recovered to pre-ischaemic values during reperfusion. The improved recovery
of the hearts in group 3, or the poorer recovery of the hearts in group 2 could thus not be
attributed to an alteration of the heart rate (Figure 4.3).
5.2.2 Coronary flow
In non-insulin treated hearts (group 2) the reperfusion coronary flow was 25% below pre-
ischaemic coronary flow. (Figure 4.4). Ischaemia is associated with a high sympathetic
activity and a subsequent high concentration of FFA in the myocardium (Gupta et al.,
1969). This has been shown to increase myocardial oxygen requirements and results in
attenuation of myocardial activity and contraction (Oliver & Opie, 1994). The reduction
of ~-oxidation of the FFA during ischaemia, results in the intracellular accumulation of
acylcamitine and acyl coenzyme A (Apstein, 2000). This accumulation may cause
impairment of the calcium homeostasis and the production of free radicals, which lead to
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instability of the contractile function of the myocardium and subsequent decrease in
coronary flow.
Addition of insulin (group 3) resulted in the recovery of the coronary flow to pre-
ischaemic values. This can probably be accounted for by the ability of insulin in the
perfusate to minimize the inhibition of glycolysis by FFA As insulin may protect the cell
membranes through a combined anti-lipolytic (Oliver & apie, 1994) and a membrane-
stabilization mechanism (Mittra, 1965), it is able to improve reflow after ischaemia and
thus improve the ability to supply the nutrient and oxygen deficient myocardium with
crucial elements to ensure better recovery and survival.
The recovery of the coronary flow of the insulin treated hearts (group 3) to pre-ischaemie
volumes, may also be attributed to the ability of insulin to increase flow (Oltman, 2000).
5.2.3 LVDP and % LVDP recovery
The LVDP of the non-insulin treated hearts (group 2) showed a 30% recovery during
reperfusion (Figure 4.5 and Figure 4.6). During ischaemia, oxygen deficiency prevents
proper oxidation of non-glucose substrates, and the myocardium becomes totally reliant
on anaerobic glycolysis and the rate of glucose utilization (apie, 1998) for its energy
requirements. As the coronary flow is impaired during ischaemia, the delivery of
substrates to re-energize the cells is slowed down, and the functional recovery is
impaired.
Reperfusion LVDP of the insulin treated hearts (in group 3) recovered to 80% of the pre-
ischaemic values. This observation again confirms the well-established fact that the
recovery of the myocardium is dependent on the hearts' ability to deliver glucose to the
myocardial cells to promote survival. Insulin stimulated both glucose entry into the
Stellenbosch University http://scholar.sun.ac.za
65
myocardial cells and glycolysis (King & apie, 1998). Combined with its ability to ensure
an improved coronary reflow after ischaemia, this promoted the functional recovery.
Another factor that may influence glucose uptake is the stimulation of the a_- and
f)-adrenergic receptors, which operate through a Ca2+ dependent mechanism (Clark &
Pattem, 1984). Ischaemia results in a significant release of endogenous
catecholamines, especially noradrenaline, which will stimulate both a_- and f)-adrenergic
receptors (Mouton et al., 1992). Both a_- and f)-stimulation will enhance myocardial
glucose uptake (Clark & Pattern, 1984). At the end of the ischaemic period, we also
observed a significant rise in the cAMP content of the insulin treated hearts (group 3)
(Figure 3.12, p.5?). It is thus a possibility that this rise in the cAMP content triggered a
mechanism in these hearts at the end of ischaemia that improved glucose uptake and
inotropic ability, and thus assisted the hearts in a more successful recovery.
Another possible explanation for the higher LVDP in the insulin treated hearts (group 3),
might be that the rise in cAMP leads to an increased intracellular Ca2+ release that
would lead to stronger contractility (Aulbach, 1999) and a subsequent increase in LVDP.
The addition of wortmannin to the perfusion solutions during both ischaemia (group 4)
and reperfusion (group 5) resulted in a significant poorer LVDP recovery during
reperfusion. Addition of wortmannin before the onset of ischaemia also abolished the
rise in cAMP, confirming the suggestion that cAMP may be important in restoring
contractile function. Wortmannin inhibits activation of PI3-Kinase, implicating this
pathway in the improved LVDP as well as the elevated cAMP levels observed.
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5.2.4 RPP and % RPP recovery
The RPP is HR multiplied by LVDP. The non-insulin treated hearts (group 2) had a 26%
RPP recovery compared to a 68% recovery of the insulin treated hearts (group 3)
(Figure 4.7and Figure 4.8).
Although the heart rates for both groups were similar, the LVDP of insulin treated hearts
were significantly higher than that of the non-insulin treated hearts. That explains the
higher RPP (P<0.05) in those hearts treated with insulin.
5.2.5 Time to onset of ischaemie contracture (TOIC)
The TOle has been used as a marker of myocardial ischaemic injury (Lasley & Mentzer,
1993). The TOle was significantly delayed, and was sometimes absent in the insulin
treated hearts (group 3) compared to the non-insulin treated hearts (group 2) (Figure
4.9). As the coronary flow in the hearts in group 2 was severely impaired at the onset of
reperfusion, it may have contributed to the accumulation of ischaemia-induced metabolic
products. The metabolism of the ischaemic myocardium is characterized by an ATP
shortage, as well as inhibition of glycolytic enzymes by the accumulation of lactate and
concomitant intracellular acidosis. Other detrimental changes include inadequate
functioning of membrane pumps (Opie, 1990), potassium (K+) loss in the ischaemic zone
(Opie, 1970; Weiss and Lamp, 1987), sarcolemmal damage (Williamson et al., 1976),
accumulation of cAMP (Wollenberger et al., 1969), and deficient ea2+ homeostasis
(Henry et al., 1977).
Several independent studies (Tani & Neely, 1989; Bolli, 1990; Opie, 1998) concluded
that a crucial factor in reperfusion injuries following ischaemia is mitochondrial calcium
accumulation, which may cause contractile dysfunction, like ischaemie contracture. As
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insulin is a known vasodilator, it might allow for improved perfusion conditions, and thus
less accumulation of deleterious substrates, even during limited ischaemic flow.
Furthermore, because of insulin's ability to increase glucose uptake, it might deliver
glucose better and quicker to the ischaemic myocardium, thus improving its metabolic
milieu and possible survival. Improved glucose uptake per se has been shown to
regulate TOIC (Owen, 1990).
5.2.6 Cyclic AMP (cAMP)
In the present study, elevated levels of cAMP were observed after 15 minutes of
ischaemia in both insulin (group 2) and non-insulin treated (group 3) hearts (Figure
4.12). A possible explanation for this could be an ischaemia-induced activation of the
beta-adrenergic signaling pathway, due to the release of endogenous catecholamines
(Mouton et al., 1992), in conjunction with a decrease in phosphodiesterase activity
(Lochner et al., 1998). The further increase in cAMP after 30 min of ischaemia in insulin
treated hearts in comparison to non-insulin treated hearts was abolished by wortmannin.
This indicates previously unreported cross signaling from the insulin stimulated signaling
pathway via activation of Pl3-Kinase to the generation of cAMP. Although evidence has
previously been presented that cAMP can stimulate PKB activity in a wortmannin
sensitive manner (Webster & Anwer, 1999), the opposite has not been reported
previously. When wortmannin was added at the onset of reperfusion, cAMP levels
during reperfusion, were unaffected.
An increase in cAMP content during ischaemia is usually associated with poorer
functional recovery. As the second messenger of beta-adrenergic catecholamine
stimulation, cAMP acts by increasing the cytosolic calcium content, which can potentially
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have adverse electrophysiological effects (Lubbe et al., 1992). Evidence for an
arrhythmogenic role of cAMP was proposed by Opie et al. (1979). They suggested that
ischaemic ventricular fibrillation was associated with increased levels of tissue cAMP in
the ischaemic zone. In contrast with their findings, Muller et al. (1986) showed that the
prevention of ventricular fibrillation by beta-adrenergic blockade was not associated with
decreased levels of cAMP, while Manning et al. (1985) found that markedly elevated
tissue cAMP levels in the rat heart, obtained by stimulating adenylate cyclase with
forskolin, did not promote ischaemic or reperfusion arrhythmias. Therefore, controversy
still exists about the role of increased levels of cyclic AMP in the myocardium during
ischaemia and reperfusion.
However, we observed significant increases in cAMP at the end of the ischaemic period
in hearts treated with insulin compared to non-insulin treated hearts. These hearts
showed improved mechanical reperfusion function despite high levels of cAMP at the
end of ischaemia. Abolishing the elevated cAMP under these conditions with
wortmannin was detrimental to recovery. These results therefore indicate that elevated
cAMP during ischaemia in the presence of insulin may be beneficial. cAMP during
reperfusion appears to be a less important parameter, as it may be washed out by
reperfusion and never shows any significant changes.
5.2.7 p38 MAPK
Numerous biochemical changes occur within the heart during ischaemia and
reperfusion, including increased oxidative stress and production of ROS (reactive
oxygen species), changes in ion homeostasis and energylfuel metabolism, decreases in
intracellular concentrations of ATP and creatine phosphate, degradation of adenosine
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nucleotides to adenosine and other nucleosides, and osmotic disturbances (Sudgen &
Clerk, 1998). These biochemical changes are associated with the activation of the p38
MAPK pathway during ischaemia and reperfusion (Clerk et aL, 1998; Seko et al., 1997;
Bogoyevitch et al., 1996).
Perfusion of hearts with a perfusion solution containing 5mM glucose in the absence of
insulin resulted in significantly higher levels of activated p38 MAPK, indicating that this
perfusion condition stressed the heart (Figure 4.13). Increased p38 MAPK was
abolished by the presence of insulin. p38 MAPK was transiently activated during
ischaemia. During reperfusion, hearts perfused in the absence of insulin presented with
high levels of activated p38 MAPK, while the presence of insulin significantly lowered
this. Wortmannin added at the onset of reperfusion partly reversed the effect of insulin.
The functional recovery of insulin treated hearts was significantly better than that of non-
insulin treated hearts, while addition of wortmannin reversed this. Functional recovery
therefore correlated inversely with the levels of activated p38 MAPK measured during
reperfusion. These results are in accordance with Bogoyevitch et al. (1996), Mackay &
Mochly-Rosen (1999), Marais, (2000) and Saurin et al. (2000). Studies by Bogoyevitch
et al. (1996) and Yin et al. (1995), showed that the activation of p38 MAPK during stress
of ischaemia, may be sustained during reperfusion. In the present study we observed
such a sustained activation of p38 MAPK during reperfusion in the non-insulin treated
hearts, while activation was transient in the insulin treated hearts. As p38 MAPK is a
stress-activated kinase, the lower activation found on reperfusion in insulin treated
hearts, may be a reflection of protection and not the cause thereof. To prove that
elevated p38 MAPK activation during reperfusion is detrimental, hearts would have to be
pefused with a specific antagonist of p38 MAPK added at the onset of reperfusion.
Addition of such an antagonist, SB203580, during ischaemia to cardiomyocytes
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expressing wild-type p38a MAPK, resulted in protection (Martin et al., 2001).
Conversely, cardiomyocytes expressing a SB203580 resistant mutant of p38a MAPK,
were not protected against ischaemia, showing that activation of p38a MAPK during
ischaemia is indeed detrimental to the myocardium.
5.2.8 PKB
The metabolic action of insulin affects every aspect of the cell, including the increase of
glucose uptake from the blood, enhanced conversion to glycogen and triacylglycerol, the
inhibition of glycogen and fat breakdown, and the promotion of protein synthesis (Mouie
& Denton, 1997). PKB is an important mediator of the physiological effects of insulin.
Treatment of cells with insulin will lead to a 20- to 50-fold activation of kinase activity and
phosphorylation of PKB (Hemmings, 1997). It is thus in accordance with these findings
that treatment with insulin in the present study resulted in a significant increase in PKB
content compared to non-insulin treated hearts (Figure 4.15).
Several studies indicate that PI3-K is involved in the regulation of PKB. These findings
indicate that the PI3-K inhibitor, wortmannin, inhibits growth factor, as well as, insulin-
induced activation of PKB (Franke et al., 1995; Burgering & Coffer, 1995; Kohn et al.,
1995).
In agreement with the results that indicated an active role for PI3-K in the activation of
PKB (Franke et al., 1995; Burgering & Coffer, 1995; Kohn et al., 1995), the current study
showed that addition of wortmannin during reperfusion successfully inhibited the
activation of PKB. This suggests that activation of PKB was thus mediated via a PI3-K
pathway.
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Konishi and colleagues (1997) investigated the effect of cellular stresses such as heat
shock, hyperosmolarity and ischaemia/reperfusion on PKB activation. As activation of
PKB by cellular stresses is insensitive to wortmannin, they concluded that it is possible
that PKB is activated by the growth factors via a PI3-K dependent pathway, and by
cellular stresses in a manner independent of PI3-K activation. As PKB was lower after
30 minutes than after 15 minutes, it is that stress-induced activity peaked at a shorter
period of ischaemia.
When neonatal rat ventricular cardiomyocytes were subjected to simulated ischaemia
and reperfusion, Punn and colleagues (2000) concluded that PKB was not activated
after ischaemia alone, but only during reperfusion following ischaemia. They found a
sustained phosphorylation of Ser473 of PKB that lasted for 2 hours. However, in the
current study, no activation of PKB was found on reperfusion in the non-insulin treated
hearts. A significant rise in the PKB activation of the insulin treated hearts after 5 and
15 min of reperfusion was documented (see Figure 4.15). This may be one way by
which insulin could assert its protection when given only at the onset of reperfusion
(Jonassen, 1996).
The functional recovery of the insulin treated hearts was significantly better than that of
the non-insulin treated hearts, and this was accompanied by a higher PKB content.
Furthermore, this improved functional recovery, similar to PKB activation could be
abolished by the addition of wortmannin. This may be explained by the downstream
effects of activation of PKB on glycolysis, glycogen synthesis, protein synthesis, glucose
transporters, and its anti-apoptotic properties. The anti-apoptotic properties of PKB
(which may be particularly important in the scenario of ischaemia-reperfusion) are
mediated through the inhibition of at least four different pathways.
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(i) PKB phosphorylates the pro-apoptotic protein BAD, and prevents it from
forming a heterodimer with the anti-apoptotic proteins Bcl-2 or Bel-XL. As
phosphorylated BAD is scavenged by the 14-3-3 scaffolding proteins, it
prevents BAD from interfering with anti-apoptotic Bcl-2 or Bel-XL (Van
Haesebroeck & Alessi, 2000).
(ii) PKB also phosphorylates and inhibits the actions of Human caspase-9, which
is a crucial protease in the initiation of apoptosis (Alnemri, 1999). Indeed,
evidence exists for the promotion of cell survival by PKB before activation of
caspase 9. It intervenes in the apoptosis cascade, even before release of
cytochrome c from the mitochondria and caspase-9 activation. This
mechanism possibly operates by maintaining the integrity of the mitochondrial
membrane (Kennedy et al., 1999).
(iii) PKB can interfere with cell-death by a transcription-based mechanism. It is
believed that PKB can phosphorylate a large family of forkhead transcription
factors (FKHR). FKHR, a human homologue of daf-16, contains three PKB
phosphorylation sites and is expressed in the liver. Reporter gene studies in
HepG2 hepatoma cells show that FKHR stimulates insulin-like growth factor-
binding protein-1 promoter activity through an IRS (insulin response
sequence), and introduction of IRSs confers this effect on a heterologous
promoter. Insulin disrupts IRS-dependent transactivation by FKHR, and
phosphorylation of Ser-256 by PKB is necessary and sufficient to mediate this
effect. Antisense studies indicate that FKHR contributes to basal promoter
function and is required to mediate effects of insulin and PKB on promoter
activity via an IRS. FKHR stimulates promoter activity through an IRS and
phosphorylation of FKHR by PKB mediates effects of insulin on gene
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expression. Signaling to FKHR-related forkhead proteins via PKB may provide
an evolutionarily conserved mechanism by which insulin and related factors
regulate gene expression (Guo et al., 1999).
5.3 Possible cross-signaling
5.3.1 cAMP and p38 MAPK
Evidence suggests that there is a significant amount of cross talk between cAMP- and
ERK-dependent signaling pathways in endothelial cell cytoskeletal organization and
barrier regulation (Liu et al., 2001). The Raf kinases serve as central intermediates to
relay signals from Ras to ERK. Cell-specific effects of these signals on growth,
differentiation and survival can be observed due to the recruitment of different
isoenzymes of the Raf family (Konig et al., 2001).
It has been proposed that the in vitro phosphorylation of a site unique to B-Raf (Ser429)
is responsible for the negative regulation of the isoenzyme by PKB. Guan et al. (2000)
showed that Ser429 is phosphorylated upon cAMP elevation in PC12 cells and
proposed that PKA is a major kinase phosphorylating the B-Raf-specific site in vivo. Raf
can thus be inhibited by both PKB and PKA. Similarly, Raf-1 is negatively regulated
through phosphorylation by both PKB and PKA.
Raf-1 phoshorylates and activates MAPK kinase, which in tum leads to the activation of
MAPK (Van Haesebroeck & Alessi, 2000). Sheth and colleagues (2001) investigated
cross signaling between the p38 MAPK and ERK pathways in neutrophils. Their data
show that p38 inhibition enhances ERK activity during endotoxemia. It is thus a
possibility that cross signaling between these two pathways may result in the activation
of the p38 MAPK pathway as a result of the inhibition of the ERK pathway via Raf by
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cAMP. Our data does not support the above signaling pathway, as our results show a
significant increase in cAMP in the insulin treated hearts at the end of the ischaemic
period, but in the same hearts we recorded control values for p38 MAPK activation.
5.3.2 cAMP and PKB
PKB can be activated by increases in intracellular cAMP concentrations in a manner that
is independent of Pl3-Kinase (Sable et al., 1997). The phosphorylation of T308 and
8473 appears to be responsible but direct phosphorylation of PKB by PKA (Sable et al.,
1997) was not found. The present study noted that the significant rise in cAMP at the
end of the ischaemic phase was accompanied by a transient activation of PKB at the
beginning of the reperfusion phase. This activation peaked at 15 minutes of reperfusion,
and attenuated towards the end of reperfusion.
The rise in the content of cAMP at the end of ischaemia could be fully abolished by
wortmannin. This indicated cross signaling from the insulin stimulated signaling pathway
to the cAMP pathway. Investigations should be performed to ascertain whether the
activation of PKB on reperfusion occurring at a time when cAMP levels are low, is
indeed a result of the PI3-K mediated rise in cAMP. As the levels of phosphorylated
PKB were low at this time point, cross signaling must either occur via a different route, or
a cascade of events must have been set in motion at an earlier stage.
4.3.3 p38 MAPK and PKB
8weeney et al. (1999) investigated the mechanism underlying insulin-stimulated glucose
transport in 3T3-L 1 adipocytes and L6 myotubes. They found that in the presence of the
p38 MAPK inhibitor, 8B203580, insulin caused normal translocation and cell surface
membrane insertion of glucose transporters without stimulating glucose transport. They
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concluded that insulin stimulates two independent signaling pathways contributing to
glucose transport: (i) The activation of PI3-K and PKB that leads to glucose transporter
translocation, and (ii) a pathway that involves p38 MAPK that may lead to the activation
of the recruited glucose transporter at the membrane. The inability of 8B203580 to
inhibit insulin-stimulated activation of all three isoforms of PKB suggest that p38 MAPK
is not in the signaling pathway leading to the activation of PKB in response to insulin. It
is thus a possibility that insulin exerts its cardioprotective effects by the parallel,
complementary operation of both the PKB and p38 MAPK signaling pathways.
When wortmannin was added to the perfusion solution (group 5) during the reperfusion
period, we observed a significant increase in the p38 MAPK activation, compared to
insulin treated hearts (group 3). The functional performance of the hearts in group 3
recovered significantly better than the hearts in group 5. We can therefore argue that
insulin might exert a cardioprotective effect by inhibiting the activation of p38 MAPK
during reperfusion after an ischaemie insult. On the other hand, the lower p38 MAPK
levels on reperfusion in the insulin treated hearts may only be an indication of lower
levels of stress and not a direct consequence of insulin signaling. As stated previously,
use of the specific p38 MAPK inhibitor 8B203580 may clarify this matter.
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Chapter 6
SUMMARY
In summary therefore this study set out to investigate the signaling pathways that insulin
might use to protect the ischaemic/reperfused myocardium. We also investigated
possible cross signaling between the different signaling pathways.
Our results demonstrated that:
(a) Insulin exerted a positive inotropic effect in control perfused hearts.
(b) Insulin, when added before, during and after low-flow ischaemia, results in
significant cardioprotection, as reflected by improved functional performance
during reperfusion.
(c) The time to onset of ischaemic contracture was delayed or absent in the
presence of insulin in the perfusate.
(d) Wortmannin, and by implication inhibition of PI3-kinase, abolished the protection
of insulin on LVDP recovery after ischaemia/reperfusion.
(e) cAMP production, as seen at the end of ischaemia in hearts subjected to
ischaemia in the presence of insulin, may playa role in the protective effects of
insulin on LVDP as this was also abolished by wortmannin. To the best of my
knowledge, this is the first demonstration of cross signaling from the insulin
cascade to production of cAMP, a messenger normally associated with beta-
adrenergic stimulation.
(f) Improved recovery was associated with attenuated activation of p38 MAPK on
reperfusion. This may be a reflection of the protected state of the heart and not
the cause thereof.
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(g) On the other hand, improved recovery is associated with activation of PKB during
early reperfusion, which might be linked to the attenuation of apoptosis
(Jonassen, 2001).
Our data shows that insulin exerts a positive inotropic effect and delays the onset to
ischaemie contracture. Inhibition of Pl3-kinase by wortmannin abolishes the protective
effects of insulin, arguing for an insulin stimulated PKB involvement in cardiac
protection. Insulin also increase cAMP production and attenuate activation of p38
MAPK, both associated with improved recovery. Our findings thus suggest possible
cross signaling between different signaling pathways.
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